Zuora and Stripe Partner to Accelerate the Growth of the Subscription Economy

Zuora and Stripe Partner to Accelerate the Growth of the Subscription Economy

SAN FRANCISCO & REDWOOD CITY, Calif.–(BUSINESS WIRE)–Zuora, Inc. (NYSE: ZUO) a leading subscription management platform provider, today announced a strategic partnership with Stripe to accelerate the growth of the Subscription Economy®. A new product integration will enable Zuora customers — including Carbar, Intercom and Seiko Epson — to enhance their subscription experience with advanced payment capabilities.

IDC predicts that, by 2023, the global economy will reach a point of digital supremacy, whereby products and services from digitally determined organizations will make up over 50% of the global GDP. “Digitally determined” enterprises will be far more proactive than their peers in building out new partner ecosystems required to monetize and deliver digital services and consuming monetized digital services delivered through the partner ecosystems.1

“Winning subscription companies want to use the best technologies to build a competitive advantage,” said Chris Battles, Chief Product Officer at Zuora. “We’re thrilled to work with Stripe in an ecosystem of new world partners that helps to optimize and automate processes throughout our customers’ journey in the Subscription Economy.”

Stripe’s Chief Business Officer Billy Alvarado, said, “Stripe’s mission is to grow the GDP of the internet, and this partnership with Zuora extends that goal by giving Zuora users access to the full capabilities of Stripe payments. With the internet powering a rapidly growing portion of the global economy, it’s never been more important to provide subscription businesses with the economic infrastructure they need.”

Zuora customers will gain access to Stripe’s industry-leading payment capabilities within their existing Zuora subscription management integration, with key benefits like:

(1)Advanced payments, fully integrated. Zuora customers will be able to take full advantage of Stripe’s advanced payment processing capabilities integrated with the Zuora platform, including fraud detection, artificial intelligence-enhanced payment retries, and payment processing capabilities – ability to pass L2 and L3 data to issuers – that reduce transaction processing costs. Stripe’s direct connections to global card networks and non-card payment methods, such as ACH, SEPA Debit and Bacs enables businesses to easily expand into new markets.

Intercom leverages the integration between Zuora and Stripe to extend the full value of Stripe’s global payments infrastructure to users around the world. Kevin Kooi, Senior Director, FP&A said, “Our customers want seamless, secure transactions in any country. Zuora’s partnership with Stripe will enable Intercom to access the latest payments features across dozens of countries to offer a best-in-class customer experience.”

(2)Payment flexibility across subscriber experiences. Companies in the Subscription Economy succeed when they deliver compelling subscription experiences that evolve with customer needs. Zuora provides the agility and automation needed to price, package, and bill in countless combinations, and now Stripe adds additional payments flexibility so subscribers can pay when, where, and how they choose.

Carbar, a subscription car company in Australia, uses Stripe and Zuora to create a more seamless subscription experience. Co-founder and CEODesmond Hang said, “Together, the Zuora and Stripe APIs give us the ability to seamlessly integrate and scale the entire order to revenue process. The latest integration will not only provide a solid foundation for us to continue pioneering the growth of car subscriptions in Australia, but will enable us to truly focus on innovating the end-to-end subscriber experience.”

(3) Future-proofed architecture. Stripe and Zuora are working together as part of a modern ecosystem for digital subscriptions and commerce to create solutions that support global businesses. The partnership gives customers the access and ability to use an architecture specific to their unique needs.

Multi-billion dollar manufacturer Seiko Epson Corp.’s Executive Officer, Junkichi Yoshida said, “As a global organization operating in countless regions, it’s critical for us to ensure seamless, reliable payment and billing processes that can scale when needed. Having experienced the benefits of Stripe and Zuora alone, the latest integration will enable us to truly optimize our ReadyPrint subscription offering, which has been deployed in nine countries so far, keep expanding, while increasing the overall success of subscription-based transactions.”

IDC Research Director Mark Thomason, responsible for the Digital Business Models and Monetization practice, said, “The Zuora and Stripe partnership brings together two leading payment and billing companies to help their customers succeed in this new digital era by combining shared insight and strategy.”

For more on the Stripe and Zuora integration, visit: https://www.zuora.com/stripe-partnership

About Stripe

Stripe is a global technology company that builds economic infrastructure for the internet. Millions of businesses of every size—from new startups to large enterprises like Salesforce, Amazon, and Slack—use Stripe to manage their online finance and treasury functions, from accepting payments to issuing credit cards to sending international payouts and growing subscription revenue. By removing complexity for users, Stripe enables companies to be adaptive to ever-changing customer behavior and participate fully in the online economy in more than 140 countries worldwide.

About Zuora, Inc.

Zuora provides the leading cloud-based subscription management platform that functions as a system of record for subscription businesses across all industries. Powering the Subscription Economy®, the Zuora platform was architected specifically for dynamic, recurring subscription business models and acts as an intelligent subscription management hub that automates and orchestrates the entire subscription order-to-revenue process seamlessly across billing and revenue recognition. Zuora serves more than 1,000 companies around the world, including Box, Ford, Penske Media Corporation, Schneider Electric, Siemens, Xplornet, and Zoom. Headquartered in Silicon Valley, Zuora also operates offices around the world in the U.S., EMEA and APAC. To learn more about the Zuora platform, please visit www.zuora.com.

© 2020 Zuora, Inc. All Rights Reserved. Zuora, Subscribed, Subscription Economy, Powering the Subscription Economy, and Subscription Economy Index are trademarks or registered trademarks of Zuora, Inc. Third party trademarks mentioned above are owned by their respective companies. Nothing in this press release should be construed to the contrary, or as an approval, endorsement or sponsorship by any third parties of Zuora, Inc. or any aspect of this press release.

1 IDC FutureScape: Worldwide Monetization 2021 Predictions, Mark Thomason, October 2020, IDC #US46246920

SOURCE: Zuora Financial

Jayne Gonzalez

[email protected]

408-348-1087

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Data Management Security Technology Mobile/Wireless Software Networks Internet

MEDIA:

Logo
Logo

Barnes & Noble Education Reports Second Quarter Fiscal Year 2021 Financial Results

Barnes & Noble Education Reports Second Quarter Fiscal Year 2021 Financial Results

Company’s Flexible Solutions Help Schools and Students Adapt to Blended and Virtual Learning Environment

BASKING RIDGE, N.J.–(BUSINESS WIRE)–Barnes & Noble Education, Inc. (NYSE: BNED), a leading solutions provider for the education industry, today reported sales and earnings for the second quarter of fiscal year 2021, which ended on October 31, 2020.

BNED’s fiscal 2021 second quarter results were significantly impacted by the ongoing COVID-19 pandemic, as many schools continued to adjust their learning model and restrict on-campus activities in response to the pandemic. Fewer students returned to campus this fall, as many schools implemented a remote learning model and curtailed on-campus classes and activities. While many big-conferences resumed their sport activities, fan attendance at the games was either eliminated or severely restricted, which further impacted the Company’s high-margin general merchandise business. Additionally, sales were impacted by overall enrollment declines in higher education.

The COVID-19 impact on higher education remains a fluid situation and BNED remains committed to supporting its campus partners through its flexible offerings and ability to quickly pivot to ensure uninterrupted service as institutions manage the safety of their campuses and the Company manages the safety of its campus stores.

Financial highlights for the second quarter 2021:

  • Consolidated second quarter sales of $595.5 million decreased 22.9%, as compared to the prior year period; year to date consolidated sales of $799.5 million decreased 26.8%, as compared to the prior year period.
  • Consolidated second quarter GAAP net income of $7.5 million, compared to GAAP net income of $35.9 million in the prior year period; year to date GAAP net loss of $39.1 million, compared to GAAP net income of $3.8 million in the prior year period.
  • Consolidated second quarter non-GAAP Adjusted Earnings of $11.1 million, compared to non-GAAP Adjusted Earnings of $37.8 million in the prior year period; year to date non-GAAP Adjusted Earnings of $(30.6) million, compared to non-GAAP Adjusted Earnings of $7.8 million in the prior year period.
  • Consolidated second quarter non-GAAP Adjusted EBITDA of $24.5 million, compared to non-GAAP Adjusted EBITDA of $74.5 million in the prior year period; year to date non-GAAP Adjusted EBITDA loss of $13.5 million, compared to non-GAAP Adjusted EBITDA $49.4 million in the prior year period.

Operational highlights for the second quarter 2021:

  • BNC First Day® year-over-year revenue increased 77%, benefitting from the accelerated move to digital courseware.
  • Successfully launched BNC First Day Complete at twelve campuses for the Fall 2020 term. The Company expects to transition additional colleges and universities to the First Day Complete model for Spring 2021.
  • Gained over 120,000 gross subscribers for the bartleby® suite of services year to date, with DSS revenue increasing 14%.
  • Continued to drive bartleby growth through search engine optimization (SEO) and partnerships with Blackboard and VitalSource, demonstrating a strong channel for growth to supplement fewer in-person selling opportunities caused by the COVID-19 pandemic.
  • Continued to attract new clients and generate new business growth, signing over $70 million in net new business to date this fiscal year and expanding BNED’s footprint by 47 BNC institutions and 31 K-12 schools.
  • Continued development of the Company’s next generation eCommerce platform; expected phased roll-out throughout calendar year 2021 to grow high-margin general merchandise sales.

“Our teams continued to make tremendous progress in growing and enhancing our offerings and services this quarter, despite the many challenges presented by the ongoing COVID-19 pandemic. As students adjusted to a blended learning environment on campuses nationwide this fall, our flexible offerings ensured that students were equipped with their course materials regardless of whether their schools resumed classes on campus, remotely or adopted a hybrid learning model,” said Michael P. Huseby, Chief Executive Officer and Chairman, BNED. “Our bartleby direct-to-student offerings became increasingly relevant in this environment, providing students with the academic support they need. We continue to scale our bartleby solutions through our existing channels, such as in-store sales and SEO, in addition to leveraging new channels, such as our recently announced Blackboard Assist partnership, to ensure we are providing widespread access to digital learning support at a time when students need it most.”

“As anticipated, we experienced lower physical textbook revenues, as well as a substantial year over year decline in our higher margin general merchandise business this quarter due to the pandemic. In addition to fewer students on campus, our general merchandise business was impacted by the cancellation of many athletic and in-store social events,” continued Mr. Huseby. “We expect the impacts of COVID-19 to extend into the new year, and as such, we are continuing to manage expenses and liquidity prudently. Our current liquidity position remains strong despite the challenging climate. As students, faculty and institutions continue to adapt to an educational landscape that is changing each day, we remain well-positioned to provide invaluable services and support to ensure all of our customers have the tools they need for success.”

Second Quarter 2021 and Year to Date Results

Results for the 13 and 26 weeks of fiscal 2021 and fiscal 2020 are as follows:

$ in millions

13 and 26 Weeks Selected Data (unaudited)

 

13 Weeks

Q2 2021

 

13 Weeks

Q2 2020

 

26 Weeks

2021

 

26 Weeks

2020

Total Sales

$595.5

 

$772.2

 

$799.5

 

$1,091.9

Net Income (Loss)

$7.5

 

$35.9

 

($39.1)

 

$3.8

Non-GAAP(1)

Adjusted EBITDA

$24.5

 

$74.5

 

($13.5)

 

$49.4

Adjusted Earnings

$11.1

 

$37.8

 

($30.6)

 

$7.8

(1) These non-GAAP financial measures have been reconciled in the attached schedules to the most directly comparable GAAP measures as required under SEC rules regarding the use of non-GAAP financial measures.

The Company has three reportable segments: Retail, Wholesale and Digital Student Solutions (DSS). Unallocated shared-service costs, which include various corporate level expenses and other governance functions, continue to be presented as Corporate Services. All material intercompany accounts and transactions have been eliminated in consolidation.

Retail Segment Results

Retail sales in the second quarter decreased by $165.2 million, or 22.3%, as compared to the prior year period. Comparable store sales in the Retail segment decreased 28.1% for the quarter, inclusive of a 52% general merchandise comparable sales decline, primarily due to fewer students on campus, curtailed campus activities and significant restrictions on attendance at sporting events.

Retail non-GAAP Adjusted EBITDA for the quarter decreased by $44.2 million to $18.3 million, as compared to non-GAAP Adjusted EBITDA of $62.6 million in the prior year period. The decrease is primarily due to lower textbook sales and lower sales of higher-margin general merchandise products, partially offset by lower selling and administrative expenses.

Wholesale Segment Results

Wholesale sales of $36.4 million for the quarter decreased by $3.8 million, or 9.5%, as compared to $40.2 million in the prior year period. The decrease is primarily due to decreased gross sales, partially offset by lower returns and allowances, both impacted by the COVID-19 pandemic.

Wholesale non-GAAP Adjusted EBITDA for the quarter was $6.6 million, as compared to non-GAAP Adjusted EBITDA of $7.9 million in the prior year period. This decrease was primarily driven by lower sales and lower gross margins, partially offset by lower selling and administrative expenses.

DSS Segment Results

DSS sales of $5.9 million for the quarter increased by $0.7 million, or 14.0%, as compared to $5.2 million in the prior year period. The increase is primarily due to an increase in sales of bartleby subscriptions.

DSS non-GAAP Adjusted EBITDA was $0.7 million for the quarter, as compared to non-GAAP Adjusted EBITDA of $0.3 million in the prior year period, benefitting from the increase in bartleby subscriptions.

Other

Expenses for Corporate Services, which includes unallocated shared-service costs, such as various corporate level expenses and other governance functions, were $5.5 million for the quarter as compared to $5.7 million in the prior period.

Intercompany gross margin eliminations of $4.4 million reflected in non-GAAP Adjusted EBITDA, compared to $9.3 million in the prior year period, are lower due to a decrease in inter-segment sales from Wholesale to Retail.

Additional Events

Pursuant to BNED’s cooperation agreement with Outerbridge, the Company nominated, and stockholders approved Zachary Levenick as an independent director at the Company’s 2020 Annual Meeting that was held on October 22, 2020.

Conference Call

A conference call with Barnes & Noble Education, Inc. senior management will be webcast at 8:30 a.m. Eastern Time on Tuesday, December 8, 2020 and can be accessed at the Barnes & Noble Education corporate website at investor.bned.com or www.bned.com.

Barnes & Noble Education expects to report fiscal 2021 third quarter results on or about March 4, 2021.

ABOUT BARNES & NOBLE EDUCATION, INC.

Barnes & Noble Education, Inc. (NYSE: BNED) is a leading solutions provider for the education industry, driving affordability, access and achievement at hundreds of academic institutions nationwide and ensuring millions of students are equipped for success in the classroom and beyond. Through its family of brands, BNED offers campus retail services and academic solutions, a digital direct-to-student learning ecosystem, wholesale capabilities and more. BNED is a company serving all who work to elevate their lives through education, supporting students, faculty and institutions as they make tomorrow a better, more inclusive and smarter world. For more information, visit www.bned.com.

Forward-Looking Statements

This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and information relating to us and our business that are based on the beliefs of our management as well as assumptions made by and information currently available to our management. When used in this communication, the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “will,” “forecasts,” “projections,” and similar expressions, as they relate to us or our management, identify forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make, including any statements made in regards to our response to the COVID-19 pandemic. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Such statements reflect our current views with respect to future events, the outcome of which is subject to certain risks, including, among others: risks associated with COVID-19 and the governmental responses to it, including its impact across our businesses on demand and operations, as well as on the operations of our suppliers and other business partners, and the effectiveness of our actions taken in response to these risks; general competitive conditions, including actions our competitors and content providers may take to grow their businesses; a decline in college enrollment or decreased funding available for students; decisions by colleges and universities to outsource their physical and/or online bookstore operations or change the operation of their bookstores; implementation of our digital strategy may not result in the expected growth in our digital sales and/or profitability; risk that digital sales growth does not exceed the rate of investment spend; the performance of our online, digital and other initiatives, integration of and deployment of, additional products and services including new digital channels, and enhancements to higher education digital products, and the inability to achieve the expected cost savings; the risk of price reduction or change in format of course materials by publishers, which could negatively impact revenues and margin; the general economic environment and consumer spending patterns; decreased consumer demand for our products, low growth or declining sales; the strategic objectives, successful integration, anticipated synergies, and/or other expected potential benefits of various acquisitions may not be fully realized or may take longer than expected; the integration of the operations of various acquisitions into our own may also increase the risk of our internal controls being found ineffective; changes to purchase or rental terms, payment terms, return policies, the discount or margin on products or other terms with our suppliers; our ability to successfully implement our strategic initiatives including our ability to identify, compete for and execute upon additional acquisitions and strategic investments; risks associated with operation or performance of MBS Textbook Exchange, LLC’s point-of-sales systems that are sold to college bookstore customers; technological changes; risks associated with counterfeit and piracy of digital and print materials; our international operations could result in additional risks; our ability to attract and retain employees; risks associated with data privacy, information security and intellectual property; trends and challenges to our business and in the locations in which we have stores; non-renewal of managed bookstore, physical and/or online store contracts and higher-than-anticipated store closings; disruptions to our information technology systems, infrastructure and data due to computer malware, viruses, hacking and phishing attacks, resulting in harm to our business and results of operations; disruption of or interference with third party web service providers and our own proprietary technology; work stoppages or increases in labor costs; possible increases in shipping rates or interruptions in shipping service; product shortages, including decreases in the used textbook inventory supply associated with the implementation of publishers’ digital offerings and direct to student textbook consignment rental programs, as well as the risks associated with the impacts that public health crises may have on the ability of our suppliers to manufacture or source products, particularly from outside of the United States; changes in domestic and international laws or regulations, including U.S. tax reform, changes in tax rates, laws and regulations, as well as related guidance; enactment of laws or changes in enforcement practices which may restrict or prohibit our use of texts, emails, interest based online advertising, recurring billing or similar marketing and sales activities; the amount of our indebtedness and ability to comply with covenants applicable to any future debt financing; our ability to satisfy future capital and liquidity requirements; our ability to access the credit and capital markets at the times and in the amounts needed and on acceptable terms; adverse results from litigation, governmental investigations, tax-related proceedings, or audits; changes in accounting standards; and the other risks and uncertainties detailed in the section titled “Risk Factors” in Part I – Item 1A in our Annual Report on Form 10-K for the year ended May 2, 2020. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results or outcomes may vary materially from those described as anticipated, believed, estimated, expected, intended or planned. Subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements in this paragraph. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this press release.

EXPLANATORY NOTE

We have three reportable segments: Retail, Wholesale and DSS as follows:

  • The Retail Segment operates 1,439 college, university, and K-12 school bookstores, comprised of 768 physical bookstores and 671 virtual bookstores. Our bookstores typically operate under agreements with the college, university, or K-12 schools to be the official bookstore and the exclusive seller of course materials and supplies, including physical and digital products. The majority of the physical campus bookstores have school-branded e-commerce sites which we operate and which offer students access to affordable course materials and affinity products, including emblematic apparel and gifts. The Retail Segment also offers inclusive access programs, in which course materials, including e-content, are offered at a reduced price through a course materials fee, and delivered to students on or before the first day of class. Additionally, the Retail Segment offers a suite of digital content and services to colleges and universities, including a variety of open educational resource-based courseware.
  • The Wholesale Segment is comprised of our wholesale textbook business and is one of the largest textbook wholesalers in the country. The Wholesale Segment centrally sources, sells, and distributes new and used textbooks to approximately 3,400 physical bookstores (including our Retail Segment’s 768 physical bookstores) and sources and distributes new and used textbooks to our 671 virtual bookstores. Additionally, the Wholesale Segment sells hardware and a software suite of applications that provides inventory management and point-of-sale solutions to approximately 400 college bookstores.
  • The Digital Student Solutions (“DSS”) Segment includes direct-to-student products and services to assist students to study more effectively and improve academic performance. The DSS Segment is comprised of the operations of Student Brands, LLC, a leading direct-to-student subscription-based writing services business, and bartleby®, a direct-to-student subscription-based offering providing textbook solutions, expert questions and answers, tutoring and test prep services.

Corporate Services represents unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources.

All material intercompany accounts and transactions have been eliminated in consolidation.

BARNES & NOBLE EDUCATION, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

 

 

13 weeks ended

 

26 weeks ended

 

October 31,

2020

 

October 26,

2019

 

October 31,

2020

 

October 26,

2019

Sales:

 

 

 

 

 

 

 

Product sales and other

$

551,832

 

 

$

718,543

 

 

$

745,042

 

 

$

1,020,770

 

Rental income

43,653

 

 

53,685

 

 

54,457

 

 

71,115

 

Total sales

595,485

 

 

772,228

 

 

799,499

 

 

1,091,885

 

Cost of sales:

 

 

 

 

 

 

 

Product and other cost of sales

452,475

 

 

553,070

 

 

618,240

 

 

791,401

 

Rental cost of sales

27,725

 

 

32,208

 

 

35,112

 

 

41,877

 

Total cost of sales

480,200

 

 

585,278

 

 

653,352

 

 

833,278

 

Gross profit

115,285

 

 

186,950

 

 

146,147

 

 

258,607

 

Selling and administrative expenses

91,972

 

 

113,404

 

 

162,015

 

 

211,095

 

Depreciation and amortization expense

13,193

 

 

15,546

 

 

27,256

 

 

31,425

 

Impairment loss (non-cash) (a)

 

 

 

 

 

 

433

 

Restructuring and other charges (a)

3,387

 

 

1,569

 

 

9,058

 

 

3,035

 

Operating income (loss)

6,733

 

 

56,431

 

 

(52,182)

 

 

12,619

 

Interest expense, net

912

 

 

1,446

 

 

3,565

 

 

3,978

 

Income before income taxes

5,821

 

 

54,985

 

 

(55,747)

 

 

8,641

 

Income tax (benefit) expense

(1,694)

 

 

19,054

 

 

(16,610)

 

 

4,865

 

Net income (loss)

$

7,515

 

 

$

35,931

 

 

$

(39,137)

 

 

$

3,776

 

 

 

 

 

 

 

 

 

Income (Loss) per common share:

 

 

 

 

 

 

 

Basic

$

0.15

 

 

$

0.75

 

 

$

(0.81)

 

 

$

0.08

 

Diluted

$

0.15

 

 

$

0.74

 

 

$

(0.81)

 

 

$

0.08

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

Basic

48,804

 

 

47,853

 

 

48,608

 

 

47,717

 

Diluted

49,428

 

 

48,758

 

 

48,608

 

 

48,412

 

(a)

For additional information, see Note (a) – (d) in the Non-GAAP disclosure information of this Press Release.

 

13 weeks ended

 

26 weeks ended

 

October 31,

2020

 

October 26,

2019

 

October 31,

2020

 

October 26,

2019

Percentage of sales:

 

 

 

 

 

 

 

Sales:

 

 

 

 

 

 

 

Product sales and other

92.7

%

 

93.0

%

 

93.2

%

 

93.5

%

Rental income

7.3

%

 

7.0

%

 

6.8

%

 

6.5

%

Total sales

100.0

%

 

100.0

%

 

100.0

%

 

100.0

%

Cost of sales:

 

 

 

 

 

 

 

Product and other cost of sales (a)

82.0

%

 

77.0

%

 

83.0

%

 

77.5

%

Rental cost of sales (a)

63.5

%

 

60.0

%

 

64.5

%

 

58.9

%

Total cost of sales

80.6

%

 

75.8

%

 

81.7

%

 

76.3

%

Gross profit

19.4

%

 

24.2

%

 

18.3

%

 

23.7

%

Selling and administrative expenses

15.4

%

 

14.7

%

 

20.3

%

 

19.3

%

Depreciation and amortization expense

2.2

%

 

2.0

%

 

3.4

%

 

2.9

%

Impairment loss (non-cash)

%

 

%

 

%

 

%

Restructuring and other charges

0.6

%

 

0.2

%

 

1.1

%

 

0.3

%

Operating income (loss)

1.2

%

 

7.3

%

 

(6.5)

%

 

1.2

%

Interest expense, net

0.2

%

 

0.2

%

 

0.4

%

 

0.4

%

Income before income taxes

1.0

%

 

7.1

%

 

(6.9)

%

 

0.8

%

Income tax (benefit) expense

(0.3)

%

 

2.5

%

 

(2.1)

%

 

0.4

%

Net income (loss)

1.3

%

 

4.6

%

 

(4.8)

%

 

0.4

%

(a)

Represents the percentage these costs bear to the related sales, instead of total sales.

BARNES & NOBLE EDUCATION, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

 

 

October 31,

2020

 

October 26,

2019

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

7,353

 

 

$

24,594

 

Receivables, net

167,493

 

 

162,538

 

Merchandise inventories, net

457,677

 

 

475,422

 

Textbook rental inventories

50,736

 

 

68,167

 

Prepaid expenses and other current assets

23,762

 

 

18,494

 

Total current assets

707,021

 

 

749,215

 

Property and equipment, net

93,130

 

 

105,156

 

Operating lease right-of-use assets

286,038

 

 

289,722

 

Intangible assets, net

166,140

 

 

184,188

 

Goodwill

4,700

 

 

4,700

 

Deferred tax assets, net

8,231

 

 

8,039

 

Other noncurrent assets

31,734

 

 

39,235

 

Total assets

$

1,296,994

 

 

$

1,380,255

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

314,042

 

 

$

387,704

 

Accrued liabilities

134,181

 

 

197,220

 

Current operating lease liabilities

121,518

 

 

107,721

 

Total current liabilities

569,741

 

 

692,645

 

Long-term operating lease liabilities

198,990

 

 

179,613

 

Other long-term liabilities

48,329

 

 

50,677

 

Long-term borrowings

99,500

 

 

 

Total liabilities

916,560

 

 

922,935

 

Commitments and contingencies

 

 

 

Stockholders’ equity:

 

 

 

Preferred stock, $0.01 par value; authorized, 5,000 shares; issued and outstanding, none

 

 

 

Common stock, $0.01 par value; authorized, 200,000 shares; issued, 53,316 and 52,139 shares, respectively; outstanding, 49,064 and 48,298 shares, respectively

533

 

 

521

 

Additional paid-in-capital

735,647

 

 

730,501

 

Accumulated deficit

(321,964)

 

 

(240,801)

 

Treasury stock, at cost

(33,782)

 

 

(32,901)

 

Total stockholders’ equity

380,434

 

 

457,320

 

Total liabilities and stockholders’ equity

$

1,296,994

 

 

$

1,380,255

 

 

 

 

 

BARNES & NOBLE EDUCATION, INC. AND SUBSIDIARIES

Sales Information

(Unaudited)

Total Sales

The components of the sales variances for the 13 and 26 week periods are as follows:

 

Dollars in millions

 

13 weeks ended

 

26 weeks ended

 

 

October 31, 2020

 

October 26, 2019

 

October 31, 2020

 

October 26, 2019

Retail Sales

 

 

 

 

 

 

 

 

New stores (a)

 

$

27.6

 

 

 

$

39.3

 

 

 

$

35.4

 

 

 

$

46.7

 

 

Closed stores (a)

 

(16.4

)

 

 

(24.5

)

 

 

(21.9

)

 

 

(32.9

)

 

Comparable stores (b)

 

(196.5

)

 

 

(45.5

)

 

 

(302.7

)

 

 

(52.3

)

 

Textbook rental deferral

 

16.4

 

 

 

1.5

 

 

 

10.1

 

 

 

2.3

 

 

Service revenue (c)

 

1.0

 

 

 

(2.0

)

 

 

(3.7

)

 

 

(2.5

)

 

Other (d)

 

2.7

 

 

 

(10.9

)

 

 

1.7

 

 

 

(15.9

)

 

Retail Sales subtotal:

 

$

(165.2

)

 

 

$

(42.1

)

 

 

$

(281.1

)

 

 

$

(54.6

)

 

Wholesale Sales:

 

$

(3.8

)

 

 

$

(0.6

)

 

 

$

4.2

 

 

 

$

(18.3

)

 

DSS Sales

 

$

0.7

 

 

 

$

0.3

 

 

 

$

1.2

 

 

 

$

 

 

Eliminations (e)

 

$

(8.4

)

 

 

$

(0.1

)

 

 

$

(16.7

)

 

 

$

12.5

 

 

Total sales variance

 

$

(176.7

)

 

 

$

(42.5

)

 

 

$

(292.4

)

 

 

$

(60.4

)

 

(a)

The following is a store count summary for physical stores and virtual stores:

 

13 weeks ended

 

26 weeks ended

 

October 31, 2020

 

October 26, 2019

 

October 31, 2020

 

October 26, 2019

Number of Stores:

Physical

Stores

 

Virtual

Stores

 

Physical

Stores

 

Virtual

Stores

 

Physical

Stores

 

Virtual

Stores

 

Physical

Stores

 

Virtual

Stores

Number of stores at beginning of period

772

 

 

670

 

 

777

 

 

714

 

 

772

 

 

647

 

 

772

 

 

676

 

Stores opened

5

 

 

11

 

 

2

 

 

9

 

 

29

 

 

51

 

 

40

 

 

55

 

Stores closed

9

 

 

10

 

 

7

 

 

59

 

 

33

 

 

27

 

 

40

 

 

67

 

Number of stores at end of period

768

 

 

671

 

 

772

 

 

664

 

 

768

 

 

671

 

 

772

 

 

664

 

(b)

For Comparable Store Sales details, see below.

(c)

Service revenue includes brand partnerships, shipping and handling, and revenue from other programs.

(d)

Other includes inventory liquidation sales to third parties, marketplace sales and certain accounting adjusting items related to return reserves, and other deferred items.

(e)

Eliminates Wholesale sales and service fees to Retail and Retail commissions earned from Wholesale.

Comparable Sales – Retail Segment

Comparable store sales variances by category for the 13 and 26 week periods are as follows:

Dollars in millions

13 weeks ended

 

26 weeks ended

 

October 31, 2020

 

October 26, 2019

 

October 31, 2020

 

October 26, 2019

Textbooks (Course Materials)

$

(101.6)

 

 

(19.0)

%

 

$

(43.9)

 

 

(7.7)

%

 

$

(112.5)

 

 

(17.5)

%

 

$

(55.4)

 

 

(8.0)

%

General Merchandise

(97.2)

 

 

(52.0)

%

 

(0.2)

 

 

(10.0)

%

 

(184.8)

 

 

(58.6)

%

 

5.7

 

 

1.9

%

Trade Books

(6.3)

 

 

(62.3)

%

 

(1.4)

 

 

(12.1)

%

 

(14.0)

 

 

(73.2)

%

 

(2.6)

 

 

(11.9)

%

Total Comparable Store Sales

$

(205.1)

 

 

(28.1)

%

 

$

(45.5)

 

 

(5.9)

%

 

$

(311.3)

 

 

(31.8)

%

 

$

(52.3)

 

 

(5.1)

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comparable store sales includes sales from physical stores that have been open for an entire fiscal year period and virtual store sales for the period, does not include sales from closed stores for all periods presented, and digital agency sales are included on a gross basis. We believe the current comparable store sales calculation method reflects the manner in which management views comparable sales, as well as the seasonal nature of our business.

BARNES & NOBLE EDUCATION, INC. AND SUBSIDIARIES

Consolidated Non-GAAP Information

(In thousands)

(Unaudited)

 

Adjusted Earnings

13 weeks ended

 

26 weeks ended

 

October 31, 2020

 

October 26, 2019

 

October 31, 2020

 

October 26, 2019

Net income (loss)

$

7,515

 

 

$

35,931

 

 

$

(39,137)

 

 

$

3,776

 

Reconciling items, after-tax (below)

3,560

 

 

1,903

 

 

8,496

 

 

3,983

 

Adjusted Earnings (Non-GAAP)

$

11,075

 

 

$

37,834

 

 

$

(30,641)

 

 

$

7,759

 

 

 

 

 

 

 

 

 

Reconciling items, pre-tax

 

 

 

 

 

 

 

Impairment loss (non-cash) (a)

$

 

 

$

 

 

$

 

 

$

433

 

Content amortization (non-cash) (b)

1,222

 

 

998

 

 

2,386

 

 

1,909

 

Restructuring and other charges (c)

3,387

 

 

1,569

 

 

9,058

 

 

3,035

 

Reconciling items, pre-tax

4,609

 

 

2,567

 

 

11,444

 

 

5,377

 

Less: Pro forma income tax impact (d)

1,049

 

 

664

 

 

2,948

 

 

1,394

 

Reconciling items, after-tax

$

3,560

 

 

$

1,903

 

 

$

8,496

 

 

$

3,983

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

13 weeks ended

 

26 weeks ended

 

October 31, 2020

 

October 26, 2019

 

October 31, 2020

 

October 26, 2019

Net income (loss)

$

7,515

 

 

$

35,931

 

 

$

(39,137)

 

 

$

3,776

 

Add:

 

 

 

 

 

 

 

Depreciation and amortization expense

13,193

 

 

15,546

 

 

27,256

 

 

31,425

 

Interest expense, net

912

 

 

1,446

 

 

3,565

 

 

3,978

 

Income tax (benefit) expense

(1,694)

 

 

19,054

 

 

(16,610)

 

 

4,865

 

Impairment loss (non-cash) (a)

 

 

 

 

 

 

433

 

Content amortization (non-cash) (b)

1,222

 

 

998

 

 

2,386

 

 

1,909

 

Restructuring and other charges (c)

3,387

 

 

1,569

 

 

9,058

 

 

3,035

 

Adjusted EBITDA (Non-GAAP)

$

24,535

 

 

$

74,544

 

 

$

(13,482)

 

 

$

49,421

 

(a)

During the 26 weeks ended October 26, 2019, we recognized an impairment loss (non-cash) of $433 in the Retail Segment related to net capitalized development costs for a project which are not recoverable.

 

(b)

Represents amortization of content development costs (non-cash) recorded in cost of goods sold in the consolidated financial statements.

 

(c)

During the 26 weeks ended October 31, 2020 and October 26, 2019, we recognized restructuring and other charges totaling $9,058 and $3,035, respectively, comprised primarily of severance and other employee termination and benefit costs associated with the elimination of various positions as part of cost reduction objectives, and professional service costs for restructuring, process improvements, and shareholder activist activities.

 

(d)

Represents the income tax effects of the non-GAAP items.

 

BARNES & NOBLE EDUCATION, INC. AND SUBSIDIARIES

Consolidated Non-GAAP Information

(In thousands)

(Unaudited)

 

Free Cash Flow (non-GAAP)

13 weeks ended

 

26 weeks ended

 

October 31, 2020

 

October 26, 2019

 

October 31, 2020

 

October 26, 2019

Adjusted EBITDA (non-GAAP)

$

24,535

 

 

$

74,544

 

 

$

(13,482)

 

 

$

49,421

 

Less:

 

 

 

 

 

 

 

Capital expenditures (a)

9,142

 

 

10,946

 

 

16,197

 

 

19,255

 

Cash interest paid

1,240

 

 

2,419

 

 

3,200

 

 

4,029

 

Cash taxes paid (refund)

85

 

 

721

 

 

6,022

 

 

(5,877)

 

Free Cash Flow (non-GAAP)

$

14,068

 

 

$

60,458

 

 

$

(38,901)

 

 

$

32,014

 

(a)

Purchases of property and equipment are also referred to as capital expenditures. Our investing activities consist principally of capital expenditures for contractual capital investments associated with renewing existing contracts, new store construction, digital initiatives and enhancements to internal systems and our website. The following table provides the components of total purchases of property and equipment:

 

 

 

 

 

 

 

 

Capital Expenditures

13 weeks ended

 

26 weeks ended

 

October 31, 2020

 

October 26, 2019

 

October 31, 2020

 

October 26, 2019

Physical store capital expenditures

$

2,825

 

 

$

4,599

 

 

$

5,962

 

 

$

8,117

 

Product and system development

2,901

 

 

4,102

 

 

5,226

 

 

7,444

 

Content development costs

1,752

 

 

1,548

 

 

2,828

 

 

2,233

 

Other

1,664

 

 

697

 

 

2,181

 

 

1,461

 

Total Capital Expenditures

$

9,142

 

 

$

10,946

 

 

$

16,197

 

 

$

19,255

 

BARNES & NOBLE EDUCATION, INC. AND SUBSIDIARIES

Segment Information

(In thousands, except percentages)

(Unaudited)

 

Segment Information (a)

13 weeks ended

 

26 weeks ended

 

October 31, 2020

 

October 26, 2019

 

October 31, 2020

 

October 26, 2019

Sales

 

 

 

 

 

 

 

Retail

$

576,514

 

$

741,769

 

$

735,290

 

$

1,016,425

Wholesale

36,387

 

40,210

 

116,681

 

112,519

DSS

5,947

 

5,215

 

11,819

 

10,589

Eliminations

(23,363)

 

(14,966)

 

(64,291)

 

(47,648)

Total

$

595,485

 

$

772,228

 

$

799,499

 

$

1,091,885

 

 

 

 

 

 

 

 

Gross profit

 

 

 

 

 

 

 

Retail (b)

$

95,704

 

$

161,150

 

$

112,049

 

$

223,473

Wholesale

10,714

 

12,535

 

27,471

 

27,453

DSS (b)

5,692

 

4,929

 

11,392

 

10,070

Eliminations

4,397

 

9,334

 

(2,379)

 

(480)

Total

$

116,507

 

$

187,948

 

$

148,533

 

$

260,516

 

 

 

 

 

 

 

 

Selling and administrative expenses

 

 

 

 

 

 

 

Retail

$

77,380

 

$

98,578

 

$

134,365

 

$

182,393

Wholesale

4,146

 

4,593

 

7,937

 

9,352

DSS

5,003

 

4,615

 

9,039

 

8,728

Corporate Services

5,501

 

5,668

 

10,745

 

10,675

Eliminations

(58)

 

(50)

 

(71)

 

(53)

Total

$

91,972

 

$

113,404

 

$

162,015

 

$

211,095

 

 

 

 

 

 

 

 

Adjusted EBITDA (Non-GAAP) (c)

 

 

 

 

 

 

 

Retail

$

18,324

 

$

62,572

 

$

(22,316)

 

$

41,080

Wholesale

6,568

 

7,942

 

19,534

 

18,101

DSS

689

 

314

 

2,353

 

1,342

Corporate Services

(5,501)

 

(5,668)

 

(10,745)

 

(10,675)

Eliminations

4,455

 

9,384

 

(2,308)

 

(427)

Total

$

24,535

 

$

74,544

 

$

(13,482)

 

$

49,421

(a)

See Explanatory Note in this Press Release for Segment descriptions.

 

(b)

For the 13 and 26 weeks ended October 31, 2020, the Retail Segment gross margin excludes $192 and $402, respectively of amortization expense (non-cash) related to content development costs. For the 13 and 26 weeks ended October 31, 2020, the DSS Segment gross margin excludes $1,030 and $1,984, respectively, of amortization expense (non-cash) related to content development costs.

 

For the 13 and 26 weeks ended October 26, 2019, the Retail Segment gross margin excludes $210 and $394 respectively of amortization expense (non-cash) related to content development costs. For the 13 and 26 weeks ended October 26, 2019, the DSS Segment gross margin excludes $788 and $1,515, respectively, of amortization expense (non-cash) related to content development costs.

 

(c)

For additional information, see “Use of Non-GAAP Financial Information” in the Non-GAAP disclosure information of this Press Release.

Percentage of Segment Sales

13 weeks ended

 

26 weeks ended

 

October 31, 2020

 

October 26, 2019

 

October 31, 2020

 

October 26, 2019

Gross margin

 

 

 

 

 

 

 

Retail

16.6

%

 

21.7

%

 

15.2

%

 

22.0

%

Wholesale

29.4

%

 

31.2

%

 

23.5

%

 

24.4

%

DSS

95.7

%

 

94.5

%

 

96.4

%

 

95.1

%

Elimination

(18.8

)%

 

(62.4

)%

 

3.7

%

 

1.0

%

Total gross margin

19.6

%

 

24.3

%

 

18.6

%

 

23.9

%

 

 

 

 

 

 

 

 

Selling and administrative expenses

 

 

 

 

 

 

 

Retail

13.4

%

 

13.3

%

 

18.3

%

 

17.9

%

Wholesale

11.4

%

 

11.4

%

 

6.8

%

 

8.3

%

DSS

84.1

%

 

88.5

%

 

76.5

%

 

82.4

%

Corporate Services

N/A

 

 

N/A

 

 

N/A

 

 

N/A

 

Elimination

N/A

 

 

N/A

 

 

N/A

 

 

N/A

 

Total selling and administrative expenses

15.4

%

 

14.7

%

 

20.3

%

 

19.3

%

 

 

 

 

 

 

 

 

Use of Non-GAAP Financial Information – Adjusted Earnings, Adjusted EBITDA and Free Cash Flow

To supplement the Company’s consolidated financial statements presented in accordance with generally accepted accounting principles (“GAAP”), in the Press Release attached hereto as Exhibit 99.1, the Company uses the non-GAAP financial measures of Adjusted Earnings (defined as net income adjusted for certain reconciling items), Adjusted EBITDA (defined by the Company as earnings before interest, taxes, depreciation and amortization, as adjusted for additional items subtracted from or added to net income) and Free Cash Flow (defined by the Company as Adjusted EBITDA less capital expenditures, cash interest and cash taxes).

These non-GAAP financial measures are not intended as substitutes for and should not be considered superior to measures of financial performance prepared in accordance with GAAP. In addition, the Company’s use of these non-GAAP financial measures may be different from similarly named measures used by other companies, limiting their usefulness for comparison purposes.

The Company’s management reviews these non-GAAP financial measures as internal measures to evaluate the Company’s performance and manage the Company’s operations. The Company’s management believes that these measures are useful performance measures which are used by the Company to facilitate a comparison of on-going operating performance on a consistent basis from period-to-period. The Company’s management believes that these non-GAAP financial measures provide for a more complete understanding of factors and trends affecting the Company’s business than measures under GAAP can provide alone, as it excludes certain items that do not reflect the ordinary earnings of its operations. The Company’s Board of Directors and management also use Adjusted EBITDA as one of the primary methods for planning and forecasting overall expected performance, for evaluating on a quarterly and annual basis actual results against such expectations, and as a measure for performance incentive plans. The Company’s management believes that the inclusion of Adjusted EBITDA and Adjusted Earnings results provides investors useful and important information regarding the Company’s operating results. The Company believes that Free Cash Flow provides useful additional information concerning cash flow available to meet future debt service obligations and working capital requirements and assists investors in their understanding of the Company’s operating profitability and liquidity as the Company manages to the business to maximize margin and cashflow.

The non-GAAP measures included in the Press Release attached hereto as Exhibit 99.1 has been reconciled to the comparable GAAP measures as required under Securities and Exchange Commission (the “SEC”) rules regarding the use of non-GAAP financial measures. All of the items included in the reconciliations below are either (i) non-cash items or (ii) items that management does not consider in assessing the Company’s on-going operating performance. The Company urges investors to carefully review the GAAP financial information included as part of the Company’s Form 10-K dated May 2, 2020 filed with the SEC on July 14, 2020, which includes consolidated financial statements for each of the three years for the period ended May 2, 2020 (Fiscal 2020, Fiscal 2019, and Fiscal 2018) and the Company’s Quarterly Report on Form 10-Q for the period ended August 1, 2020 filed with the SEC on September 3, 2020.

Media Contact:

Carolyn J. Brown

Senior Vice President

Corporate Communications & Public Affairs

(908) 991-2967

[email protected]

Investor Contact:

Andy Milevoj

Vice President

Corporate Finance & Investor Relations

(908) 991-2776

[email protected]

KEYWORDS: United States North America New Jersey

INDUSTRY KEYWORDS: University Other Retail Primary/Secondary Education Technology Specialty Other Technology Training Retail Other Education Continuing

MEDIA:

Logo
Logo

Wiley Reports Second Quarter Fiscal 2021 Results

Wiley Reports Second Quarter Fiscal 2021 Results

HOBOKEN, N.J.–(BUSINESS WIRE)–
John Wiley & Sons, Inc. (NYSE:JWA)(NYSE:JWB), a global leader in research and education, today announced results for the second quarter ended October 31, 2020.

SECOND QUARTER SUMMARY

  • GAAP Results: Revenue of $491 million (+5%) and EPS of $1.22 (+54%)
  • Adjusted Results (at constant currency): Revenue +4% to $491 million, EBITDA +7% to $120 million, and EPS +12% to $1.00
  • Research Publishing & Platforms (at constant currency): Revenue +5% and Adjusted EBITDA +14% on strong double-digit growth in Open Access
  • Academic & Professional Learning: Revenue for Education Publishing marginally ahead of prior year as accelerated growth in digital content and courseware more than offset decline in print books
  • Education Services: Second Quarter and First Half Adjusted EBITDA margin of 21% and 17%, trending ahead of FY22 target of 15%

MANAGEMENT COMMENTARY

“Wiley’s consistent strategies in open research and online education continued to deliver strong returns with record research output and content consumption, robust online enrollment growth, and broad digital courseware adoption,” said Brian Napack, President and CEO. “The pandemic is accelerating important trends underlying our core strategies, including a global increase in the demand to publish and access high-quality research and a decisive shift to online learning and digital curriculums.”

SECOND QUARTER PERFORMANCE

GAAP Measures

Unaudited ($millions except for EPS)

Q2 2021

Q2 2020

Change

 

Revenue

$491.0

$466.2

5%

Diluted EPS

$1.22

$0.79

54%

Non-GAAP Measures

Q2 2021

Q2 2020

Change

Constant Currency

Revenue

$491.0

$466.2

4%

Adjusted EBITDA

$120.3

$110.0

7%

Adjusted EPS

$1.00

$0.85

12%

Excluding acquisitions and currency impact, revenue was flat for the quarter. Wiley recorded a favorable FX variance of $8 million in revenue, $0.05 in Adjusted EPS, and $2 million in Adjusted EBITDA.

Revenue

  • Research Publishing & Platforms rose 7% as reported and 5% at constant currency with strong growth in open access and content platforms driving results.
  • Academic & Professional Learning declined 4% as reported and 5% at constant currency mainly due to COVID-19 impact on Professional Learning (-11% reported, -13% constant currency), particularly trade books and in-person corporate training. Within Education Publishing (+1%, 0% constant currency), digital content and courseware growth accelerated, more than offsetting the decline in print textbooks, while test prep continued its sharp decline due to COVID-related exam cancellations.
  • Education Services increased 28% as reported and 27% at constant currency, driven by the three-month inorganic contribution from mthree (+$13 million) and organic constant currency growth of 6% in Online Program Management (OPM) services.

Adjusted EBITDA

  • Research Publishing & Platforms grew 14% at constant currency, reflecting revenue growth, operational efficiencies, and COVID-related expense savings.
  • Academic & Professional Learning declined 10% at constant currency, reflecting revenue performance partly offset by business optimization gains and COVID-related expense savings.
  • Education Services rose 94% at constant currency from $8 million to $15 million, driven by revenue growth and business optimization initiatives, notably sustained improvement in student acquisition costs. Adjusted EBITDA margin for the quarter was 21%, up from 14% in the prior year.
  • Corporate Expenses rose 10% to $41 million mainly due to the timing of annual incentive costs.

EPS

  • GAAP EPS of $1.22 compared to $0.79 in the prior year period and primarily reflected higher Operating Income, lower restructuring charges and interest expense, and a $0.25 discrete tax benefit. In connection with the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), Wiley elected to carry back its fiscal year 2020 U.S. loss for tax purposes to its fiscal year 2015, resulting in a $14 million GAAP tax benefit this quarter.
  • Adjusted EPS of $1.00 compared to $0.85 in the prior year and was driven by improved Adjusted Operating Income. The $0.25 discrete tax benefit related to the CARES Act was excluded from Adjusted EPS.

Balance Sheet and Liquidity

  • Net debt-to-EBITDA ratio (trailing twelve months) at quarter-end was 1.9 as compared to 1.8 at the end of the year-ago period.
  • Available liquidity was approximately $740 million at quarter-end, including $86 million of cash on hand and $655 million of undrawn credit capacity.

Cash Flow (Six Months)

  • Net Cash Used in Operating Activities was $77 million compared to $100 million in the prior year period, primarily driven by improved earnings, partly offset by unfavorable timing of changes in working capital. Note, the Company’s use of cash in the first half of the fiscal year is driven by the timing of collections for annual journal subscriptions, which is concentrated in the third and fourth fiscal quarters.
  • Free Cash Flow less Product Development Spending was a use of $124 million compared to a use of $156 million in the prior year, primarily reflecting the improvement in Net Cash Used in Operating Activities.

FISCAL YEAR 2021 OUTLOOK

Based on performance through the six months and leading indicators for the remainder of the year, Wiley is initiating annual guidance for fiscal year 2021. For Revenue, the Company anticipates low-single digit growth overall, which includes low-single digit growth in Research, a mid-single digit decline in Academic & Professional Learning, and double-digit growth in Education Services (mid-single digit growth on an organic basis). Projected performance ranges for consolidated Revenue, Adjusted EBITDA, Adjusted EPS and Free Cash Flow are as follows:

METRIC (in millions, except EPS)

FY20

FY21 OUTLOOK*

Revenue

$1,831

$1,865 – $1,885

Adjusted EBITDA

$356

$380 – $395

Adjusted EPS

$2.40

$2.50 – $2.70

Free Cash Flow

$173

$175 – $200

*Outlook reflects actual currency for results through Q2 and assumes current FX rates prevail for remainder of year.

EARNINGS CONFERENCE CALL

Scheduled for today, December 8 at 10:00 a.m. (ET). Access the webcast on Wiley.com, at https://www.wiley.com/en-us/investors or directly at https://edge.media-server.com/mmc/p/xdo3rqb2. U.S. callers, please dial (844) 231-0103 and enter the participant code 6272694#. International callers, please dial (216) 562-0402 and enter the participant code 6272694#.

ABOUT WILEY

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help researchers, professionals, students, universities, and corporations to achieve their goals in an ever-changing world. And for more than 200 years, we have delivered consistent performance to all our stakeholders. The Company’s website can be accessed at www.wiley.com.

NON-GAAP FINANCIAL MEASURES

Wiley provides non-GAAP financial measures and performance results such as “Adjusted EPS,” “Adjusted Revenue,” “Adjusted Operating Income,” “Adjusted EBITDA,” “Adjusted CTP,” “Free Cash Flow less Product Development Spending,” “organic revenue,” and results on a Constant Currency basis to assess underlying business performance and trends. Management believesnon-GAAP financial measures, which exclude the impact of restructuring charges and credits and certain other items, and the impact of acquisitions provide a useful comparable basis to analyze operating results and earnings. See the reconciliations of non-GAAP financial measures and explanations of the uses of non-GAAP measures in the supplementary information.

FORWARD-LOOKING STATEMENTS

This release contains certain forward-looking statements concerning the Company’s operations, performance, and financial condition. Reliance should not be placed on forward-looking statements, as actual results may differ materially from those in any forward-looking statements. Any such forward-looking statements are based upon a number of assumptions and estimates that are inherently subject to uncertainties and contingencies, many of which are beyond the control of the Company and are subject to change based on many important factors. Such factors include, but are not limited to: (i) the level of investment in new technologies and products; (ii) subscriber renewal rates for the Company’s journals; (iii) the financial stability and liquidity of journal subscription agents; (iv) the consolidation of book wholesalers and retail accounts; (v) the market position and financial stability of key online retailers; (vi) the seasonal nature of the Company’s educational business and the impact of the used book market; (vii) worldwide economic and political conditions; (viii) the Company’s ability to protect its copyrights and other intellectual property worldwide (ix) the ability of the Company to successfully integrate acquired operations and realize expected opportunities; (x) the Company’s ability to realize operating savings over time and in fiscal year 2021 in connection with our multi-year Business Optimization Program; (xi) the impact of COVID-19 on our operations, performance, and financial condition; and (xii) other factors detailed from time to time in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

Category: Earnings Releases

 

JOHN WILEY & SONS, INC.

SUPPLEMENTARY INFORMATION (1)(2)
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share data)
(unaudited)
 
Three Months Ended Six Months Ended
October 31, October 31,

2020

 

2019

 

2020

 

2019

Revenue, net

$ 491,011

$ 466,205

$ 922,337

$ 889,735

Costs and expenses:
Cost of sales

154,853

143,413

299,662

286,509

Operating and administrative expenses

247,167

240,380

484,536

490,550

Restructuring and related charges

1,920

4,001

4,138

14,736

Amortization of intangibles

17,166

15,020

34,057

29,990

Total Costs and Expenses

421,106

402,814

822,393

821,785

 
Operating Income

69,905

63,391

99,944

67,950

As a % of revenue

14.2%

13.6%

10.8%

7.6%

 
Interest expense

(4,461)

(6,787)

(9,075)

(12,864)

Foreign exchange transaction losses

(697)

(2,668)

(779)

(16)

Other income

3,766

2,537

8,157

5,370

Income Before Taxes

68,513

56,473

98,247

60,440

 
Provision for income taxes

81

11,783

13,481

12,126

Effective tax rate

0.1%

20.9%

13.7%

20.1%

Net Income

$ 68,432

$ 44,690

$ 84,766

$ 48,314

As a % of revenue

13.9%

9.6%

9.2%

5.4%

 
Weighed Average Number of Common Shares Outstanding
Basic

56,005

56,326

55,959

56,431

Diluted

56,165

56,664

56,182

56,791

 
Earnings Per Share
Basic

$ 1.22

$ 0.79

$ 1.51

$ 0.86

Diluted

$ 1.22

$ 0.79

$ 1.51

$ 0.85

Notes:
(1) The supplementary information included in this press release for the three and six months ended October 31, 2020 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
(2) All amounts are approximate due to rounding.
 

JOHN WILEY & SONS, INC.

SUPPLEMENTARY INFORMATION (1)
RECONCILIATION OF GAAP EPS to NON-GAAP ADJUSTED EPS – DILUTED
(unaudited)
 
Three Months Ended Six Months Ended
October 31, October 31,

2020

 

2019

 

2020

 

2019

GAAP Earnings Per Share – Diluted

$ 1.22

$ 0.79

$ 1.51

$ 0.85

Adjustments:
Restructuring and related charges (A)

0.02

0.06

0.05

0.20

Foreign exchange losses (gains) on intercompany transactions (A)

0.01

(0.02)

0.01

Impact of increase in U.K. statutory rate on deferred tax balances (B)

0.12

Impact of U.S. CARES Act (C)

(0.25)

(0.25)

Non-GAAP Adjusted Earnings Per Share – Diluted

$ 1.00

$ 0.85

$ 1.41

$ 1.06

 
Notes:
(A) The table below shows the net of tax impact of our adjustments to GAAP Earnings Per Share noted above.
Three Months Ended Six Months Ended
October 31, October 31,
(amounts in millions)

2020

 

2019

 

2020

 

2019

Net of tax, charges related to the Business Optimization Program

$ 1.4

$ 2.8

$ 2.9

$ 11.1

Net of tax, (credits) charges related to the Restructuring and Reinvestment Program

$ (0.2)

$ 0.3

$ (0.2)

$ 0.2

Net of tax, foreign exchange transaction losses (gains)

$ 0.2

$ 0.5

$ (0.8)

$ 0.7

 
(B) During the first quarter of fiscal 2021, the U.K. officially enacted legislation that increased its statutory rate from 17% to 19%. This resulted in a $6.7 million non-cash deferred tax expense from the re-measurement of the Company’s applicable U.K. net deferred tax liabilities.
(C) In connection with the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) and certain regulations issued in late July 2020, the Company elected to carry back its fiscal year 2020 loss for tax purposes (“NOL”) to its fiscal year 2015 and claimed a $20.7 million refund. The NOL carryback to a year when our corporate tax rate was 35%, including certain related benefits, resulted in a $14 million tax benefit. We expect to receive the refund by the end of fiscal 2021.
(1) See Explanation of Usage of Non-GAAP performance measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors. The supplementary information included in this press release for the three and six months ended October 31, 2020 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
 

JOHN WILEY & SONS, INC.

SUPPLEMENTARY INFORMATION (1)
RECONCILIATION OF GAAP NET INCOME to NON-GAAP EBITDA AND ADJUSTED EBITDA
(unaudited)
 
Three Months Ended Six Months Ended
October 31, October 31,

2020

 

2019

 

2020

 

2019

Net Income

$ 68,432

$ 44,690

$ 84,766

$ 48,314

Interest expense

4,461

6,787

9,075

12,864

Provision for income taxes

81

11,783

13,481

12,126

Depreciation and amortization

48,430

42,638

97,937

84,857

Non-GAAP EBITDA

121,404

105,898

205,259

158,161

Restructuring and related charges

1,920

4,001

4,138

14,736

Foreign exchange transaction losses

697

2,668

779

16

Other income

(3,766)

(2,537)

(8,157)

(5,370)

Non-GAAP Adjusted EBITDA

$ 120,255

$ 110,030

$ 202,019

$ 167,543

Adjusted EBITDA Margin

24.5%

23.6%

21.9%

18.8%

Notes:
(1) See Explanation of Usage of Non-GAAP performance measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors. The supplementary information included in this press release for the three and six months ended October 31, 2020 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
 

JOHN WILEY & SONS, INC.

SUPPLEMENTARY INFORMATION (1)
SEGMENT RESULTS
(in thousands)
(unaudited)
 
% Change
Three Months Ended October 31, Favorable (Unfavorable)

2020

2019

Reported Constant Currency
Research Publishing & Platforms:
Revenue, net
Research Publishing

$ 240,691

$ 225,085

7%

5%

Research Platforms

10,643

9,624

11%

11%

Total Revenue, net

$ 251,334

$ 234,709

7%

5%

 
Contribution to Profit

$ 74,088

$ 63,291

17%

15%

Adjustments:
Restructuring (credits) charges

(238)

726

Non-GAAP Adjusted Contribution to Profit

$ 73,850

$ 64,017

15%

14%

Depreciation and amortization

19,765

17,037

Non-GAAP Adjusted EBITDA

$ 93,615

$ 81,054

15%

14%

Adjusted EBITDA margin

37.2%

34.5%

 
Academic & Professional Learning:
Revenue, net
Education Publishing

$ 103,105

$ 101,741

1%

0%

Professional Learning

67,485

75,984

-11%

-13%

Total Revenue, net

$ 170,590

$ 177,725

-4%

-5%

 
Contribution to Profit

$ 29,878

$ 35,050

-15%

-17%

Adjustments:
Restructuring charges

1,541

800

Non-GAAP Adjusted Contribution to Profit

$ 31,419

$ 35,850

-12%

-15%

Depreciation and amortization

17,720

17,349

Non-GAAP Adjusted EBITDA

$ 49,139

$ 53,199

-8%

-10%

Adjusted EBITDA margin

28.8%

29.9%

 
Education Services:
Revenue, net
Education Services OPM (2)

$ 56,261

$ 52,781

7%

6%

mthree (2)

12,826

990

# #
Total Revenue, net

$ 69,087

$ 53,771

28%

27%

 
Contribution to Profit

$ 7,425

$ 2,583

# #
Adjustments:
Restructuring charges (credits)

84

(475)

Non-GAAP Adjusted Contribution to Profit

$ 7,509

$ 2,108

# #
Depreciation and amortization

7,210

5,522

Non-GAAP Adjusted EBITDA

$ 14,719

$ 7,630

93%

94%

Adjusted EBITDA margin

21.3%

14.2%

 
Corporate Expenses:

$ (41,486)

$ (37,533)

-11%

-10%

Adjustments:
Restructuring charges

533

2,950

Non-GAAP Adjusted Corporate Expenses

$ (40,953)

$ (34,583)

-18%

-18%

Depreciation and amortization

3,735

2,730

Non-GAAP Adjusted EBITDA

$ (37,218)

$ (31,853)

-17%

-16%

 
Consolidated Results:
Revenue, net

$ 491,011

$ 466,205

5%

4%

 
Operating Income

$ 69,905

$ 63,391

10%

8%

Adjustments:
Restructuring charges

1,920

4,001

Non-GAAP Adjusted Operating Income

$ 71,825

$ 67,392

7%

4%

Depreciation and amortization

48,430

42,638

Non-GAAP Adjusted EBITDA

$ 120,255

$ 110,030

9%

7%

Adjusted EBITDA margin

24.5%

23.6%

(1) The supplementary information included in this press release for the three and six months ended October 31, 2020 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
(2) In May 2020, we moved the IT bootcamp business acquired as part of The Learning House acquisition from Education Services OPM to mthree. As a result, the prior period revenue related to the IT bootcamp business has been included in mthree. There were no changes to our total Education Services or our consolidated financial results. The inorganic revenue from mthree in the three and six months ended October 31, 2020 was $12.5 and $24.9 million, respectively.
 
# Variance greater than 100%
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION (1)
SEGMENT RESULTS
(in thousands)
(unaudited)
% Change
Six Months Ended October 31, Favorable (Unfavorable)

2020

2019

Reported Constant Currency
Research Publishing & Platforms:
Revenue, net
Research Publishing

$ 471,155

$ 445,012

6%

5%

Research Platforms

20,989

19,072

10%

10%

Total Revenue, net

$ 492,144

$ 464,084

6%

5%

 
Contribution to Profit

$ 143,906

$ 118,937

21%

20%

Adjustments:
Restructuring (credits) charges

(435)

3,346

Non-GAAP Adjusted Contribution to Profit

$ 143,471

$ 122,283

17%

16%

Depreciation and amortization

39,466

34,190

Non-GAAP Adjusted EBITDA

$ 182,937

$ 156,473

17%

16%

Adjusted EBITDA margin

37.2%

33.7%

 
Academic & Professional Learning:
Revenue, net
Education Publishing

$ 167,189

$ 167,264

0%

0%

Professional Learning

130,314

155,319

-16%

-17%

Total Revenue, net

$ 297,503

$ 322,583

-8%

-8%

 
Contribution to Profit

$ 29,498

$ 39,961

-26%

-28%

Adjustments:
Restructuring charges

1,574

3,605

Non-GAAP Adjusted Contribution to Profit

$ 31,072

$ 43,566

-29%

-30%

Depreciation and amortization

36,524

33,873

Non-GAAP Adjusted EBITDA

$ 67,596

$ 77,439

-13%

-14%

Adjusted EBITDA margin

22.7%

24.0%

 
Education Services:
Revenue, net
Education Services OPM(2)

$ 106,523

$ 100,937

6%

6%

mthree (2)

26,167

2,131

# #
Total Revenue, net

$ 132,690

$ 103,068

29%

28%

 
Contribution to Profit

$ 7,983

$ (4,616)

# #
Adjustments:
Restructuring charges

223

1,614

Non-GAAP Adjusted Contribution to Profit

$ 8,206

$ (3,002)

# #
Depreciation and amortization

14,489

11,020

Non-GAAP Adjusted EBITDA

$ 22,695

$ 8,018

# #
Adjusted EBITDA margin

17.1%

7.8%

 
Corporate Expenses:

$ (81,443)

$ (86,332)

6%

6%

Adjustments:
Restructuring charges

2,776

6,171

Non-GAAP Adjusted Corporate Expenses

$ (78,667)

$ (80,161)

2%

2%

Depreciation and amortization

7,458

5,774

Non-GAAP Adjusted EBITDA

$ (71,209)

$ (74,387)

4%

4%

 
Consolidated Results:
Revenue, net

$ 922,337

$ 889,735

4%

3%

 
Operating Income

$ 99,944

$ 67,950

47%

44%

Adjustments:
Restructuring charges

4,138

14,736

Non-GAAP Adjusted Operating Income

$ 104,082

$ 82,686

26%

24%

Depreciation and amortization

97,937

84,857

Non-GAAP Adjusted EBITDA

$ 202,019

$ 167,543

21%

19%

Adjusted EBITDA margin

21.9%

18.8%

 
# Variance greater than 100%

JOHN WILEY & SONS, INC.

SUPPLEMENTARY INFORMATION (1)
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(in thousands)
(unaudited)
 
October 31, April 30,

2020

2020

Assets:
Current Assets
Cash and cash equivalents

$ 86,063

$ 202,464

Accounts receivable, net

273,264

309,384

Inventories, net

42,169

43,614

Prepaid expenses and other current assets

75,801

59,465

Total Current Assets

477,297

614,927

 
Product Development Assets, net

48,944

53,643

Royalty Advances, net

18,276

36,710

Technology, Property and Equipment, net

290,071

298,005

Intangible Assets, net

819,834

807,405

Goodwill

1,126,904

1,116,790

Operating Lease Right-of-Use Assets

137,095

142,716

Other Non-Current Assets

101,984

98,598

Total Assets

$ 3,020,405

$ 3,168,794

 
Liabilities and Shareholders’ Equity:
Current Liabilities
Accounts payable

$ 54,911

$ 93,691

Accrued royalties

94,390

87,408

Short-term portion of long-term debt

12,500

9,375

Contract liabilities

285,176

520,214

Accrued employment costs

88,761

108,448

Accrued income taxes

1,901

13,728

Short-term portion of operating lease liabilities

20,071

21,810

Other accrued liabilities

77,026

72,595

Total Current Liabilities

634,736

927,269

Long-Term Debt

825,243

765,650

Accrued Pension Liability

173,084

187,969

Deferred Income Tax Liabilities

131,026

119,127

Operating Lease Liabilities

153,355

159,782

Other Long-Term Liabilities

82,748

75,373

Total Liabilities

2,000,192

2,235,170

Shareholders’ Equity

1,020,213

933,624

Total Liabilities and Shareholders’ Equity

$ 3,020,405

$ 3,168,794

(1) The supplementary information included in this press release for October 31, 2020 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
 

JOHN WILEY & SONS, INC.

SUPPLEMENTARY INFORMATION (1)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(in thousands)
(unaudited)
 
Six Months Ended
October 31,

2020

2019

Operating Activities:
Net income

$ 84,766

$ 48,314

Amortization of intangibles

34,057

29,990

Amortization of product development assets

17,448

17,616

Depreciation and amortization of technology, property, and equipment

46,432

37,251

Other non-cash charges and credits

72,521

59,302

Net change in operating assets and liabilities

(331,846)

(291,994)

Net Cash Used In Operating Activities

(76,622)

(99,521)

 
Investing Activities:
Additions to technology, property, and equipment

(36,430)

(44,531)

Product development spending

(10,999)

(11,686)

Businesses acquired in purchase transactions, net of cash acquired

(229)

(74,169)

Acquisitions of publication rights and other

(14,021)

(4,045)

Net Cash Used in Investing Activities

(61,679)

(134,431)

 
Financing Activities:
Net debt borrowings

59,590

317,471

Cash dividends

(38,480)

(38,486)

Purchase of treasury shares

(25,000)

Other

(2,511)

(4,718)

Net Cash Provided By Financing Activities

18,599

249,267

 
Effects of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash

3,301

(461)

 
Change in Cash, Cash Equivalents and Restricted Cash for Period

(116,401)

14,854

 
Cash, Cash Equivalents and Restricted Cash – Beginning

203,047

93,548

Cash, Cash Equivalents and Restricted Cash – Ending

$ 86,646

$ 108,402

 
CALCULATION OF NON-GAAP FREE CASH FLOW LESS PRODUCT DEVELOPMENT SPENDING
 
Six Months Ended
October 31,

2020

2019

Net Cash Used In Operating Activities

$ (76,622)

$ (99,521)

Less: additions to technology, property, and equipment

(36,430)

(44,531)

Less: product development spending

(10,999)

(11,686)

Free Cash Flow less Product Development Spending

$ (124,051)

$ (155,738)

 
See Explanation of Usage of Non-GAAP Measures included in this supplemental information.
(1) The supplementary information included in this press release for the six months ended October 31, 2020 is preliminary and subject to change prior
to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.

JOHN WILEY & SONS, INC.

Explanation of Usage of NON-GAAP Performance Measures

In this earnings release and supplemental information, management may present the following non-GAAP performance measures:

  • Adjusted Earnings Per Share (“Adjusted EPS”);
  • Free Cash Flow less Product Development Spending;
  • Adjusted Revenue;
  • Adjusted Operating Income and margin;
  • Adjusted Contribution to Profit and margin;
  • EBITDA, Adjusted EBITDA and margin;
  • Organic revenue; and
  • Results on a constant currency basis.

Management uses these non-GAAP performance measures as supplemental indicators of our operating performance and financial position as well for internal reporting and forecasting purposes, when publicly providing its outlook, to evaluate the Company’s performance and calculate incentive compensation. Non-GAAP performance measures do not have standardized meanings prescribed by U.S. GAAP and therefore may not be comparable to the calculation of similar measures used by other companies and should not be viewed as alternatives to measures of financial results under U.S. GAAP.

The Company presents these non-GAAP performance measures in addition to U.S. GAAP financial results because it believes that these non-GAAP performance measures provide useful information to investors and financial analysts for operational trends and comparisons over time. The use of these non-GAAP performance measures may also provide a consistent basis to evaluate operating profitability and performance trends by excluding items that we do not consider to be controllable activities for this purpose. For example:

  • Adjusted EPS, Adjusted Revenue, Adjusted Operating Income, Adjusted Contribution to Profit, Adjusted EBITDA and organic revenue provide a more comparable basis to analyze operating results and earnings and are measures commonly used by shareholders to measure our performance.
  • Free Cash Flow less Product Development Spending helps assess our ability, over the long term, to create value for our shareholders as it represents cash available to repay debt, pay common stock dividends and fund share repurchases and acquisitions.
  • Results on a constant currency basis removes distortion from the effects of foreign currency movements to provide better comparability of our business trends from period to period. We measure our performance before the impact of foreign currency (or at “constant currency”), which means that we apply the same foreign currency exchange rates for the current and equivalent prior period.

In addition, the Company has historically provided these or similar non-GAAP performance measures and understand that some investors and financial analysts find this information helpful in analyzing the Company’s operating margins, and net income and comparing the Company’s financial performance to that of its peer companies and competitors. Based on interactions with investors, we also believe that the Company’s non-GAAP performance measures are regarded as useful to our investors as supplemental to our U.S. GAAP financial results, and that there is no confusion regarding the adjustments or our operating performance to our investors due to the comprehensive nature of our disclosures.

Investors:

Brian Campbell

201.748.6874

[email protected]

Media:

Katie Roberts

602.373.7233

[email protected]

KEYWORDS: New Jersey United States North America

INDUSTRY KEYWORDS: Education Other Education Primary/Secondary

MEDIA:

Logo
Logo

Seagen Highlights TUKYSA® (tucatinib) Data in Breast Cancer at Virtual 2020 SanAntonio Breast Cancer Symposium

Seagen Highlights TUKYSA® (tucatinib) Data in Breast Cancer at Virtual 2020 SanAntonio Breast Cancer Symposium

New analyses from the pivotal HER2CLIMB trial describe outcomes by hormone receptor status –

BOTHELL, Wash.–(BUSINESS WIRE)–Seagen Inc. (Nasdaq:SGEN) today announced the presentation of new data from TUKYSA (tucatinib), its HER2-positive metastatic breast cancer therapy, at the San Antonio Breast Cancer Symposium (SABCS) Virtual Symposium, taking place December 8-11, 2020. Nine abstracts – including two spotlight posters – highlight the company’s commitment to addressing unmet needs in breast cancer.

“Following this year’s FDA approval of TUKYSA, we continue to broadly study if more patients may benefit from this important medicine,” said Roger Dansey, M.D., Chief Medical Officer at Seagen. “Data presented at the meeting from the HER2CLIMB trial demonstrate TUKYSA’s efficacy regardless of patients’ hormone receptor status, while other clinical and preclinical findings provide new insights about TUKYSA’s potential to help patients living with HER2-positive metastatic breast cancer.”

Highlights for key data presentations at the meeting include:

Efficacy Outcomes by Hormone Receptor Status from HER2CLIMB Trial

Outcomes for TUKYSA® (tucatinib) in combination with trastuzumab and capecitabine in patients with HER2-positive metastatic breast cancer from the pivotal HER2CLIMB trial by hormone receptor (HR) status will be featured in a spotlight poster (Abstract #PD3-08). Results will be presented by Erika P. Hamilton, M.D., Director, Breast Cancer and Gynecologic Cancer Research Program at the Sarah Cannon Research Institute.

As previously reported, the addition of TUKYSA to trastuzumab and capecitabine resulted in clinically meaningful improvements in overall survival (OS), progression-free survival (PFS) and objective response rate (ORR) compared to the addition of placebo. The new exploratory analyses presented at SABCS demonstrated that the PFS, OS and ORR improvements with TUKYSA were observed consistently across hormone receptor status subgroups, including in patients with brain metastases.

SABCS 2020 Data Presentations for Seagen Medicines and Pipeline Agents:

Below are presentation details related to TUKYSA and the investigational agent ladiratuzumab vedotin at SABCS. Published abstracts can be found here. Poster presentations will be available on December 9, 2020.

Abstract Title

Abstract No.

Presentation

Type / Date

Presenter

Tucatinib versus placebo in combination with trastuzumab and capecitabine for patients with locally advanced unresectable or HER2-positive metastatic breast cancer (HER2CLIMB): outcomes by hormone receptor status

#PD3-08

Spotlight Poster Discussion 3 – Wednesday, Dec. 9 from 6:45 – 7:45 p.m. CT

E. Hamilton

Impact of tucatinib on health-related quality of life in patients with HER2+ metastatic breast cancer with stable and active brain metastases

#PD13-04

Spotlight Poster Discussion 13 – Friday, Dec. 11 from 1 – 2:15 p.m. CT

A. Wardley

Tucatinib favourably modulates the immune microenvironment and synergises with anti-PD1 therapy in a trastuzumab resistant HER2+ murine model

#PS10-04

Poster Session 10 / Wednesday, Dec. 9 at 8 a.m. CT

R. Li

Tucatinib potentiates the activity of the antibody-drug conjugate T-DM1 in preclinical models of HER2-positive breast cancer

#PS10-08

Poster Session 10 / Wednesday, Dec. 9 at 8 a.m. CT

A. Kulukian

Real world treatment patterns and healthcare resource utilization among HER2+ metastatic breast cancer patients with and without brain metastases: a retrospective cohort study

#PS14-15

Poster Session 14 / Wednesday, Dec. 9 at 8 a.m. CT

C. Ike

Interim safety and efficacy analysis of phase IB/II clinical trial of tucatinib, palbociclib and letrozole in patients with hormone receptor and HER2-positive metastatic breast cancer

#PS10-03

Poster Session 10 / Wednesday, Dec. 9 at 8 a.m. CT

E. Shagisultanova

Trials-in-Progress

HER2CLIMB-02: A randomized, double-blind, phase 3 study of tucatinib or placebo with T-DM1 for unresectable locally-advanced or metastatic HER2+ breast cancer

#OT-28-01

Ongoing Trials Posters / Wednesday, Dec. 9 at 8 a.m. CT

S. Hurvitz

SGNLVA-001: a phase 1 open-label dose escalation and expansion study of SGN-LIV1A administered weekly in breast cancer

#OT-03-03

Ongoing Trials Posters / Wednesday, Dec. 9 at 8 a.m. CT

H.C. Beckwith

About TUKYSA (tucatinib)

TUKYSA is an oral medicine that is a tyrosine kinase inhibitor of the HER2 protein. In vitro (in lab studies), TUKYSA inhibited phosphorylation of HER2 and HER3, resulting in inhibition of downstream MAPK and AKT signaling and cell growth (proliferation), and showed anti-tumor activity in HER2-expressing tumor cells. In vivo (in living organisms), TUKYSA inhibited the growth of HER2-expressing tumors. The combination of TUKYSA and the anti-HER2 antibody trastuzumab showed increased anti-tumor activity in vitro and in vivo compared to either medicine alone. In the U.S., TUKYSA is approved in combination with trastuzumab and capecitabine for adult patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases (disease that has spread to the brain), who have received one or more prior anti-HER2-based regimens in the metastatic setting. TUKYSA is approved in the U.S., Switzerland, Canada, Singapore and Australia and is under review in the European Union. As part of a strategic collaboration announced in September 2020 with Merck, known as MSD outside the United States and Canada, Merck has exclusive rights to commercialize TUKYSA in Asia, the Middle East and Latin America and other regions outside of the U.S., Canada and Europe.

U.S. Important Safety Information

Warnings and Precautions

  • Diarrhea – TUKYSA can cause severe diarrhea including dehydration, hypotension, acute kidney injury, and death. In HER2CLIMB, 81% of patients who received TUKYSA experienced diarrhea, including 12% with Grade 3 diarrhea and 0.5% with Grade 4 diarrhea. Both patients who developed Grade 4 diarrhea subsequently died, with diarrhea as a contributor to death. The median time to onset of the first episode of diarrhea was 12 days and the median time to resolution was 8 days. Diarrhea led to dose reductions of TUKYSA in 6% of patients and discontinuation of TUKYSA in 1% of patients. Prophylactic use of antidiarrheal treatment was not required on HER2CLIMB.

    If diarrhea occurs, administer antidiarrheal treatment as clinically indicated. Perform diagnostic tests as clinically indicated to exclude other causes of diarrhea. Based on the severity of the diarrhea, interrupt dose, then dose reduce or permanently discontinue TUKYSA.

  • Hepatotoxicity – TUKYSA can cause severe hepatotoxicity. In HER2CLIMB, 8% of patients who received TUKYSA had an ALT increase >5 × ULN, 6% had an AST increase >5 × ULN, and 1.5% had a bilirubin increase >3 × ULN (Grade ≥3). Hepatotoxicity led to dose reduction of TUKYSA in 8% of patients and discontinuation of TUKYSA in 1.5% of patients.

    Monitor ALT, AST, and bilirubin prior to starting TUKYSA, every 3 weeks during treatment, and as clinically indicated. Based on the severity of hepatotoxicity, interrupt dose, then dose reduce or permanently discontinue TUKYSA.

  • Embryo-Fetal Toxicity – TUKYSA can cause fetal harm. Advise pregnant women and females of reproductive potential risk to a fetus. Advise females of reproductive potential, and male patients with female partners of reproductive potential, to use effective contraception during TUKYSA treatment and for at least 1 week after the last dose.

Adverse Reactions

Serious adverse reactions occurred in 26% of patients who received TUKYSA. Serious adverse reactions in ≥2% of patients who received TUKYSA were diarrhea (4%), vomiting (2.5%), nausea (2%), abdominal pain (2%), and seizure (2%). Fatal adverse reactions occurred in 2% of patients who received TUKYSA including sudden death, sepsis, dehydration, and cardiogenic shock.

Adverse reactions led to treatment discontinuation in 6% of patients who received TUKYSA; those occurring in ≥1% of patients were hepatotoxicity (1.5%) and diarrhea (1%). Adverse reactions led to dose reduction in 21% of patients who received TUKYSA; those occurring in ≥2% of patients were hepatotoxicity (8%) and diarrhea (6%).

The most common adverse reactions in patients who received TUKYSA (≥20%) were diarrhea, palmar-plantar erythrodysesthesia, nausea, fatigue, hepatotoxicity, vomiting, stomatitis, decreased appetite, abdominal pain, headache, anemia, and rash.

Lab Abnormalities

In HER2CLIMB, Grade ≥3 laboratory abnormalities reported in ≥5% of patients who received TUKYSA were: decreased phosphate, increased ALT, decreased potassium, and increased AST. The mean increase in serum creatinine was 32% within the first 21 days of treatment with TUKYSA. The serum creatinine increases persisted throughout treatment and were reversible upon treatment completion. Consider alternative markers of renal function if persistent elevations in serum creatinine are observed.

Drug Interactions

  • Strong CYP3A or Moderate CYP2C8 Inducers: Concomitant use may decrease TUKYSA activity. Avoid concomitant use of TUKYSA.
  • Strong or Moderate CYP2C8 Inhibitors: Concomitant use of TUKYSA with a strong CYP2C8 inhibitor may increase the risk of TUKYSA toxicity; avoid concomitant use. Increase monitoring for TUKYSA toxicity with moderate CYP2C8 inhibitors.
  • CYP3A Substrates: Concomitant use may increase the toxicity associated with a CYP3A substrate. Avoid concomitant use of TUKYSA where minimal concentration changes may lead to serious or life-threatening toxicities. If concomitant use is unavoidable, decrease the CYP3A substrate dosage.
  • P-gp Substrates: Concomitant use may increase the toxicity associated with a P-gp substrate. Consider reducing the dosage of P-gp substrates where minimal concentration changes may lead to serious or life-threatening toxicity.

Use in Specific Populations

  • Lactation: Advise women not to breastfeed while taking TUKYSA and for at least 1 week after the last dose.
  • Renal Impairment: Use of TUKYSA in combination with capecitabine and trastuzumab is not recommended in patients with severe renal impairment (CLcr < 30 mL/min), because capecitabine is contraindicated in patients with severe renal impairment.
  • Hepatic Impairment: Reduce the dose of TUKYSA for patients with severe (Child-Pugh C) hepatic impairment.

For more information, please see the full Prescribing Information for TUKYSA here.

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.

Forward Looking Statements

Certain statements made in this press release are forward looking, such as those, among others, relating to the therapeutic potential of TUKYSA including its efficacy, safety and therapeutic uses. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include the difficulty and uncertainty of pharmaceutical product development, the risk of adverse events or safety signals, the inability to show sufficient activity in clinical trials and the possibility of adverse regulatory actions. More information about the risks and uncertainties faced by Seagen is contained under the caption “Risk Factors” included in the company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 filed with the Securities and Exchange Commission. Seagen disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Peggy Pinkston

(425) 527-4160

[email protected]

KEYWORDS: Washington United States North America

INDUSTRY KEYWORDS: Research Hospitals Clinical Trials Biotechnology Health Pharmaceutical General Health Science Oncology

MEDIA:

Logo
Logo

Sequans Communications S.A. Announces Pricing of Public Secondary Offering of American Depositary Shares

Sequans Communications S.A. Announces Pricing of Public Secondary Offering of American Depositary Shares

PARIS–(BUSINESS WIRE)–
Sequans Communications S.A. (NYSE: SQNS), (“Sequans” or the “Company”), a leading developer and provider of 5G and 4G chips and modules for IoT devices, today announced the pricing of an underwritten public secondary offering of 2,529,961 American Depositary Shares (the “ADSs”), at a price of $5.50 per ADS. Each ADS represents four ordinary shares of the Company, nominal value €0.02 per share. The ADSs to be sold in the offering will be offered by Nokomis Capital Master Fund, L.P. (“Nokomis”) and will be issued pursuant to the conversion of $12.4 million in principal and accrued paid-in-kind interest of Sequans’ convertible notes. The Company has granted the underwriters a 30-day option to purchase an additional 379,494 ADSs to cover over-allotments, if any. The Company intends to use the net proceeds from the over-allotment option, if exercised, for general corporate purposes, including the payment of certain expenses associated with the secondary offering. The offering is expected to close on December 10, 2020, subject to customary closing conditions.

B. Riley Securities is acting as sole bookrunner for the offering.

The offering is being made pursuant to the Company’s shelf registration statement on Form F-3 (File No. 333-250122) that was declared effective by the Securities and Exchange Commission (“SEC”) on November 24, 2020. The ADSs may be offered only by means of a prospectus. A preliminary prospectus supplement and the accompanying base prospectus relating to the offering was filed with the SEC on December 7, 2020, and a final prospectus supplement and accompanying base prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Copies of the final prospectus supplement and accompanying base prospectus relating to this offering may also be obtained, when available, by contacting B. Riley Securities, Inc., Attention: Prospectus Department, 1300 17th St. North, Ste. 1300, Arlington, VA 22209, or by email at [email protected], or by telephone at (703) 312-9580.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Sequans Communications

Sequans Communications S.A. (NYSE: SQNS) is a leading developer and provider of 5G and 4G chips and modules for IoT devices. For 5G/4G massive IoT applications, Sequans provides a comprehensive product portfolio based on its flagship Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms, featuring industry-leading low power consumption, a large set of integrated functionalities, and global deployment capability. For 5G/4G broadband and critical IoT applications, Sequans offers a product portfolio based on its Cassiopeia 4G Cat 4/Cat 6 and high-end Taurus 5G chip platforms, optimized for low-cost residential, enterprise, and industrial applications. Founded in 2003, Sequans is based in Paris, France with additional offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Taiwan, South Korea, and China.

Forward-Looking Statements

This press release contains forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). Words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “will,” and similar expressions are intended to identify forward-looking statements. The forward-looking statements in this press release include statements about the Company’s expectations regarding the completion of the secondary public offering and the anticipated use of proceeds from the over-allotment option, if any. These statements involve risks, estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed in these statements, including, among others, risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the proposed offering, as well as risks and uncertainties associated with the Company’s business and finances in general. In addition, please refer to the risk factors contained in the Company’s Form 20-F for the fiscal year ended December 31, 2019 and other SEC filings available at www.sec.gov. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date on which they are made. The Company undertakes no obligation to update or revise any forward-looking statements for any reason, except as required by law.

Disclaimer

The announcement is for information purposes only and does not, and shall not, in any circumstances, constitute a public offering by Sequans, nor a solicitation of an offer to subscribe for securities in any jurisdiction outside the United States, including France. No prospectus (including any amendment, supplement or replacement thereto) or any other offering material has been prepared in connection with the offering of the ADSs that has been approved by the Autorité des marchés financiers or by the competent authority of another State that is a contracting party to the Agreement on the European Economic Area and notified to the Autorité des marchés financiers; no ADSs have been offered or sold nor will be offered or sold, directly or indirectly, to the public in France; the prospectus or any other offering material relating to the ADSs have not been distributed or caused to be distributed and will not be distributed or caused to be distributed to the public in France; such offers, sales and distributions have been and shall only be made in France to persons licensed to provide the investment service of portfolio management for the account of third parties, qualified investors (investisseurs qualifiés) and/or restricted circle of investors (cercle restreint d’investisseurs), in each case investing for their own account, all as defined in Articles L. 411-2, D. 411-1, D. 411-4, D.744-1, D.754-1 and D. 764-1 of the FrenchCode monétaire et financier. The direct or indirect distribution to the public in France of any so acquired ADSs may be made only as provided by Articles L. 411-1, L. 411-2, L. 412-1 and L. 621-8 to L. 621-8-3 of the French Code monétaire et financier and applicable regulations thereunder. This communication does not constitute an offer or invitation to subscribe for or to purchase any of the ADSs and neither this communication nor anything herein shall form the basis of any contract or commitment whatsoever. Any contact with potential qualified investors in France does not and will not constitute financial and banking solicitation (démarchage bancaire et financier) as set forth in Articles L. 341-1 and seq. of the French Code monétaire et financier.

Media Relations: Kimberly Tassin, +1.425.736.0569, [email protected]

Investor Relations: Claudia Gatlin, +1 212.830.9080, [email protected]

KEYWORDS: France Europe

INDUSTRY KEYWORDS: Telecommunications Networks Internet Hardware Data Management Technology Semiconductor Mobile/Wireless

MEDIA:

Logo
Logo

CrowdStrike Services Cyber Front Lines Report Reveals Widespread Remote Work Has Broad-Reaching Effects on Cybersecurity

CrowdStrike Services Cyber Front Lines Report Reveals Widespread Remote Work Has Broad-Reaching Effects on Cybersecurity

Report reveals 68% of organizations that fell victim to an intrusion experienced an additional intrusion attempt, and traditional antivirus solutions failed in 40% of observed incidents

SUNNYVALE, Calif.–(BUSINESS WIRE)–CrowdStrike, a leader in cloud-delivered endpoint and workload protection, today announced the release of the annual CrowdStrike Services Cyber Front Lines Report, which brings together the insights and observations of CrowdStrike’s global incident response (IR) and proactive services teams in 2020. The report not only provides an in-depth look into how adversaries are adapting to today’s realities but also offers recommendations for organizations to improve their cybersecurity readiness in 2021.

The CrowdStrike Services Cyber Front Lines Report reveals the broad-reaching impact remote work has had on cybersecurity, as corporate networks around the world were turned inside out to accommodate remote workers. This, in turn, had dramatic effects on how attackers targeted organizations and how defenders reacted, especially with the accelerated adoption of cloud infrastructure.

Notable findings include:

  • Intrusions are no longer a one-time event. The CrowdStrike Services team observed organizations that experienced an intrusion and then leveraged CrowdStrike to manage their endpoint protection and remediation efforts moving forward. CrowdStrike identified that 68% of those organizations experienced another intrusion attempt, which was prevented.
  • Buying technology alone is not enough without full configuration and deployment. In at least 30% of incident response engagements, CrowdStrike observed the organization’s antivirus solutions were either incorrectly configured with weak prevention settings or not fully deployed across the environment, which may have been a factor in the threat actor gaining and maintaining access. Antivirus solutions failed to provide protection in 40% of the incidents CrowdStrike responded to in 2020, in which either malware was undetected or a portion of the attack sequence was missed by antivirus tools.
  • Weaknesses in public-facing applications and services are increasingly dangerous. CrowdStrike observed significant increases in attackers targeting public-facing applications and services in 2020.
  • 2020 brings staggering increase in volume and velocity of financially motivated attacks. Of these financially motivated attacks, 81% involved the deployment of ransomware or a precursor to ransomware activities, while only 19% included eCrime attacks such as point-of-sale intrusions, ecommerce website attacks, business email compromise and cryptocurrency mining.
  • State-sponsored adversaries leave smaller footprints. In parallel to the rapid rise of eCrime, state-sponsored adversaries remained active across a wide range of sectors.
  • Outside counsel plays a bigger role in the incident response process. Outside counsel retained CrowdStrike to advise its clients in 49% of the incidents investigated in 2020.

“Remote work has redefined the playing field between cyber attackers and defenders, and that’s clearly demonstrated in the CrowdStrike Services Cyber Front Lines Report. Corporate networks now span both office and home, providing a wealth of new attack surfaces and vectors that adversaries can exploit,” said Shawn Henry, chief security officer and president of CrowdStrike Services at CrowdStrike. “Holistic coordination and continued vigilance are key in detecting and stopping sophisticated intrusions. Because of this, we’re seeing a necessary shift from one-off emergency engagements to continuous monitoring and response. This will better enable incident response teams to help customers drastically reduce the average time to detect, investigate and remediate from 162 hours to less than 60 minutes.”

The CrowdStrike Services Cyber Front Lines Report reflects data derived from CrowdStrike Services incident response, managed services and proactive services engagements over 2020, spanning 15 industry sectors, residing in 34 countries and varied in size from large global organizations to regionally focused small/mid-sized businesses (SMBs).

To download a copy of the CrowdStrike Services Cyber Front Lines Report, visit this page.

To read more from CrowdStrike’s Shawn Henry on key findings within the report, visit this blog.

About CrowdStrike

CrowdStrike, a global cybersecurity leader, is redefining security for the cloud era with an endpoint and workload protection platform built from the ground up to stop breaches. The CrowdStrike Falcon® platform’s single lightweight-agent architecture leverages cloud-scale artificial intelligence (AI) and offers real-time protection and visibility across the enterprise, preventing attacks on endpoints and workloads on or off the network. Powered by the proprietary CrowdStrike Threat Graph®, CrowdStrike Falcon correlates 4 trillion endpoint-related events per week in real time from across the globe, fueling one of the world’s most advanced data platforms for security.

With CrowdStrike, customers benefit from better protection, better performance and immediate time-to-value delivered by the cloud-native Falcon platform.

There’s only one thing to remember about CrowdStrike: We stop breaches.

Qualifying organizations can gain full access to Falcon Prevent™ by starting a free trial.

Learn more: https://www.crowdstrike.com/

Follow us: Blog | Twitter

© 2020 CrowdStrike, Inc. All rights reserved. CrowdStrike, the falcon logo, CrowdStrike Falcon and CrowdStrike Threat Graph are marks owned by CrowdStrike, Inc. and registered with the United States Patent and Trademark Office, and in other countries. CrowdStrike owns other trademarks and service marks, and may use the brands of third parties to identify their products and services.

CrowdStrike

Ilina Cashiola, 202-340-0517

[email protected]

KEYWORDS: California Australia/Oceania United States United Kingdom North America Australia Europe

INDUSTRY KEYWORDS: Data Management Security Technology Other Technology Software Networks

MEDIA:

Logo
Logo

Lineage Cell Therapeutics Provides Update on OPC1 Cell Therapy Program for the Treatment of Spinal Cord Injury

Lineage Cell Therapeutics Provides Update on OPC1 Cell Therapy Program for the Treatment of Spinal Cord Injury

Major Improvements Made to OPC1 Production, Including to Process, Purity, Potency, and Scale

CARLSBAD, Calif.–(BUSINESS WIRE)–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today provided an update on OPC1, its oligodendrocyte progenitor cell (OPC) allogeneic transplant for the treatment of acute spinal cord injuries (SCI). The Company reported it has developed an enhanced differentiation process, leading to major improvements in production and quality of its OPC1 cell therapy drug product, including:

  • A new ready-to-inject formulation of OPC1, which enables clinical use at a much larger number of spinal cord treatment centers, accelerating enrollment for a larger and potentially registrational clinical trial.
  • Elimination of dose preparation, reducing overall preparation time from 24 hours to 30 minutes and cutting logistics costs by approximately 90%.
  • A 10 to 20-fold increase in OPC1 production scale, sufficient to support late-stage clinical development and which can be further scaled to meet initial commercial use.
  • A 50-75% reduction in product impurities.
  • Improvements in OPC1 functional activity, as assessed by cellular migration and secretion of key growth factors.
  • Development of 12 new analytical and functional methods for in-process quality control and release of improved product.
  • Elimination of all animal-based production reagents resulting in a xeno-free final product formulation, consistent with guidelines preferred by U.S. and European regulatory agencies.
  • Filing of patent applications on the process and product which, if allowed, are anticipated to have expiration dates in 2039 and 2040.

“Manufacturing is the foundation of cell therapy and the significant enhancements we have achieved with OPC1 marks the second time we have successfully transformed a research-grade production process into one capable of supporting a successful commercial product. The first instance was with OpRegen, our dry AMD program, from which we now can generate 5 billion 99% pure RPE cells in a single 3-liter bioreactor. We’ve achieved similar value-creating improvements with the production of oligodendrocytes for our spinal cord program and I expect we also will be successful with our next endeavor, modernizing the production of allogeneic dendritic cells to support our immuno-oncology platform,” stated Brian M. Culley, Lineage CEO. “Our objective is to be the premier allogeneic cell therapy company and our dedication to manufacturing excellence allows us not only to reduce or eliminate certain regulatory and commercial hurdles, but also establish strong competitive barriers in our field. Looking ahead, we are reviewing our options to return OPC1 to clinical testing in a late-stage, comparative clinical trial and evaluating bespoke delivery solutions for our OPC1 cells.”

A further discussion of the manufacturing improvements made to the OPC1 program will be available today at 12:00 pm Eastern Time / 9:00 am Pacific Time on an analyst-led webinar hosted by FORCE Wealth. Mr. Culley and Brandi Roberts, Lineage’s CFO, will participate in a fireside chat hosted by Joseph Pantginis, Ph.D., Managing Director, Equity Research at H.C. Wainwright & Co., LLC. Interested investors can access the live presentation on the Events and Presentations section of Lineage’s website and an archived presentation will be available for 30 days. Additional videos are available on the Media page of the Lineage website, located at www.lineagecell.com/media/.

About Spinal Cord Injuries

A spinal cord injury (SCI) occurs when the spinal cord is subjected to a severe crush or contusion and frequently results in severe functional impairment, including limb paralysis, aberrant pain signaling, and loss of bladder control and other body functions. There are approximately 18,000 new spinal cord injuries annually in the U.S. There are no FDA-approved drugs specifically for the treatment of SCI. The cost of a lifetime of care for a severe spinal cord injury can be as high as $5 million.

About OPC1

OPC1 is an oligodendrocyte progenitor cell (OPC) transplant therapy designed to provide clinically meaningful improvements in motor recovery in individuals with acute spinal cord injuries (SCI). OPCs are naturally occurring precursors to the cells which provide electrical insulation for nerve axons in the form of a myelin sheath. The OPC1 program has been partially funded by a $14.3 million grant from the California Institute for Regenerative Medicine. OPC1 has received Regenerative Medicine Advanced Therapy (RMAT) designation and Orphan Drug designation from the U.S. Food and Drug Administration (FDA).

About the OPC1 Clinical Study

The SCiStar Study of OPC1 is an open-label, 25-patient, single-arm trial testing three sequential escalating doses of OPC1 administered 21 to 42 days post-injury in patients with subacute motor complete (AIS-A or AIS-B) cervical (C-4 to C-7) acute spinal cord injuries (SCI). Patient enrollment in this study is complete; 96% of patients reported one level of improved motor function and 33% of patients reported two levels of improved motor function. Patients continue to be evaluated on a long-term basis. Patients enrolled in the SCiStar study had experienced severe paralysis of the upper and lower limbs. The primary endpoint in the SCiStar study was safety as assessed by the frequency and severity of adverse events related to OPC1, the injection procedure, and immunosuppression with short-term, low-dose tacrolimus. Secondary outcome measures included neurological functions measured by upper extremity motor scores (UEMS) and motor level on International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) examinations through 365 days post-treatment.

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical programs are in markets with billion dollar opportunities and include three allogeneic (“off-the-shelf”) product candidates: (i) OpRegen®, a retinal pigment epithelium transplant therapy in Phase 1/2a development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; and (iii) VAC, an allogeneic dendritic cell therapy platform for immuno-oncology and infectious disease, currently in clinical development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com or follow the Company on Twitter @LineageCell.

Forward-Looking Statements

Lineage cautions you that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “design,” “intend,” “expect,” “could,” “plan,” “potential,” “predict,” “seek,” “should,” “would,” “contemplate,” project,” “target,” “tend to,” or the negative version of these words and similar expressions. Such statements include, but are not limited to, statements relating to Lineage’s manufacturing improvements and anticipated patent expiration dates. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Lineage’s actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including risks and uncertainties inherent in Lineage’s business and other risks in Lineage’s filings with the Securities and Exchange Commission (the SEC). Lineage’s forward-looking statements are based upon its current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. Further information regarding these and other risks is included under the heading “Risk Factors” in Lineage’s periodic reports with the SEC, including Lineage’s Annual Report on Form 10-K filed with the SEC on March 12, 2020 and its other reports, which are available from the SEC’s website. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Lineage undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

Lineage Cell Therapeutics, Inc. IR

Ioana C. Hone

([email protected])

(442) 287-8963

Solebury Trout IR

Gitanjali Jain Ogawa

([email protected])

(646) 378-2949

Russo Partners – Media Relations

Nic Johnson or David Schull

[email protected]

[email protected]

(212) 845-4242

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Biotechnology Health Genetics Pharmaceutical Clinical Trials

MEDIA:

Logo
Logo

Albertsons Companies Foundation Donates $14 Million to Organizations Fighting Hunger

Albertsons Companies Foundation Donates $14 Million to Organizations Fighting Hunger

Includes major grants of up to $500,000 to organizations with innovative projects to eradicate hunger; nearly 150 organizations receive grants of up to $100,000

BOISE, Idaho–(BUSINESS WIRE)–
Albertsons Companies Foundation is awarding almost $14 million in grants from its Nourishing Neighbors community relief fund to local hunger-fighting organizations in areas their stores serve from coast to coast.

The grants include almost $4 million for 13 large grants to organizations across the United States as part of Nourishing Neighbors’ new innovation grant program, which awards grants up to $500,000 to organizations with innovative projects or new ideas for eradicating hunger.

“The Nourishing Neighbors Innovation Grants are for organizations that we believe can have a transformative impact on hunger relief,” said Christy Duncan Anderson, President and Executive Director of Albertsons Companies Foundation. “Their innovative ideas range from creating greater buying power for non-profits to furthering SNAP outreach. We’re excited to help their innovative ideas come to fruition.”

Grant recipients were selected from more than 500 applicants by a committee consisting of Albertsons Companies Foundation staff, board members, and the Foundation’s five partner organizations. The organizations below were selected for their innovative ideas that have the potential for wide-reaching impact by scaling to other organizations:

Campaign to End Childhood Hunger – California: Plans to implement improved policies to maximize the ability of Pandemic-EBT to feed low-income children and establish a Summer EBT program in California.

D.C. Hunger Solutions: Is convening a College Hunger Task Force to address college student food insecurity, collect data on post-COVID student hunger, and develop resources based on the Task Force’s findings.

End Hunger Connecticut: Will use the grant funds tocreate a buying group for non-profit organizations throughout the state to leverage their buying power.

Foundation for Impact on Literacy and Learning: Expects to educate students on hunger issues by creating a National middle-school program on the topic of hunger.

The Jacobs & Cushman San Diego Food Bank: Hopes to implement “Feeding Everyone with Equity and Dignity program (FEED),” utilizing Oasis Insights database technology to help clientele of non-profit organizations maximize the services available to them.

Maryland Hunger Solutions: Is expanding their remote Supplemental Nutrition Assistance Program (SNAP) outreach capacity in the state of Maryland.

mRelief: Will expand the use of digital tools to simplify the SNAP application process.

New Hope Community Ministries: Looks forward to starting a buying club to help reduce purchasing costs and increase food access to more residents.

Northwest Harvest: Plans to launch a leadership program for people who have experienced hunger through their Campaign for Food as a Human Right.

Partners for a Hunger Free Oregon: Wants to start a food assistance program for vulnerable groups who don’t currently have access to federal hunger-relief programs.

Vouchers 4 Veggies (San Francisco General Hospital Foundation – fiscal sponsor): Will implement a produce debit card that would allow for widespread adoption of produce prescription programs.

The Denver Health Foundation: Will develop a process to facilitate co-enrollment in WIC and SNAP during regularly scheduled clinical visits.

Virginia Poverty Law: Hopes to use the grant to create a SNAP hotline and maintain their current SNAP calculator and benefits estimator.

In addition to the innovation grants, Nourishing Neighbors is awarding grants of up to $100,000 to more than 140 organizations serving marginalized and vulnerable populations. These grants are awarded to nonprofit organizations who serve in communities where Albertsons Cos. operates and are dedicated to eradicating hunger in BIPOC communities (Black, Indigenous and People of Color) either by increasing capacity to serve or better understanding of the needs of the community. Interested organizations can review the grant application requirements on the Albertsons Companies Foundation website.

The funds for these grants come from the $53 million Albertsons Companies committed earlier this year to the Nourishing Neighbors community relief initiative to address increasing hunger issues caused by the pandemic.

Nourishing Neighbors is a charitable program of the Albertsons Companies Foundation, which is working to eradicate hunger in America.

Albertsons Cos. has a long-standing commitment to hunger relief. In the last five years, the company has donated more than $2 billion in product to food banks and other hunger relief agencies, expanding their standing as one of the biggest retail supporters of hunger relief in the country. These donations were in addition to hundreds of tons of food contributed through local and regional food drives. For more information about Albertsons Cos.’ commitment to hunger relief, please visit here.

About Albertsons Companies

Locally great and nationally strong, Albertsons Companies is a leading food and drug retailer in the United States. The company operates stores across 34 states and the District of Columbia under 20 well-known banners including Albertsons, Safeway, Vons, Jewel-Osco, Shaw’s, Acme, Tom Thumb, Randalls, United Supermarkets, Pavilions, Star Market, Haggen and Carrs. The company is committed to helping people across the country live better lives by making a meaningful difference, neighborhood by neighborhood. In 2019 alone, along with the Albertsons Companies Foundation, the Company gave $225 million in food and financial support. In 2020, the Company made a $53 million commitment to community hunger relief efforts and a $5 million commitment to organizations supporting social justice. These efforts have helped millions of people in the areas of hunger relief, education, cancer research and treatment, social justice and programs for people with disabilities and veterans’ outreach. 

Andrew Whelan

[email protected]

KEYWORDS: Idaho United States North America

INDUSTRY KEYWORDS: Fund Raising Foundation Retail Philanthropy Supermarket

MEDIA:

Wolters Kluwer enhances its CCH® ProSystem fx® Engagement solution with new Engagement Organizer features

Wolters Kluwer enhances its CCH® ProSystem fx® Engagement solution with new Engagement Organizer features

Cloud collaboration, automatic notification, and document tracking help simplify the process of requesting, receiving, and tracking documents & notes from clients during an audit engagement

NEW YORK–(BUSINESS WIRE)–
Today, Wolters Kluwer Tax & Accounting announced the addition of new features to the Engagement Organizer in its award-winning CCH® ProSystem fx® Engagement integrated audit management solution. With new Engagement Organizer capabilities, clients can now easily upload documents into a secure portal by the date required by their auditor. Firms can upload templates or documents their clients need to complete and take advantage of tools that facilitate the back-and-forth dialogue for questions and notes.

“It’s amazing to hear customers tell us that Engagement Organizer is saving them between 30 minutes to an hour per audit during audit preparation,” said Cathy Rowe, CPA, CA and Director of Accounting and Audit Product Management at Wolters Kluwer Tax & Accounting North America. “Our goal was to provide auditors with a simpler process for requesting, receiving, and tracking documents and notes with their audit clients. It’s incredibly rewarding when that tool also provides good ROI.”

New Engagement Organizer features include:

  • Identity Management application. Secure method for firm and client users to set up profile information used for securely identifying the user when authenticating for Engagement Organizer
  • New login process. Firm staff must now provide the firm’s CCH account number when logging into Engagement Organizer and emails sent from Engagement Organizer to client users provides a new URL link that includes their unique login ID
  • Retention end date. A retention end date can now be set for each organizer based on a firm’s file retention policies. Users can search for organizers based on the retention end date to locate organizers that should be considered for deletion
  • Cloud collaboration. Firm staff can quickly and easily request and share information with customers from anywhere, at any time
  • Document request tracking. Auditors and clients can easily track all requested documents throughout the duration of the engagement
  • Automatic notifications. Staff gets automatically notified when an organizer is ready for the client, when changes are made by the auditor or the client, and when requests are outstanding and the due date is approaching

Wolters Kluwer Integrated Audit Approach focuses the audit process on auditor judgment, covering the entire end-to-end workflow to maximize efficiencies and guide firms to a higher quality audit avoiding over or under auditing. This unique approach facilitates their ability to make informed decisions by ensuring that the audit is tailored for each client, always having a link to the assessed risk and the work performed. It combines the powerful content-driven tools of CCH® ProSystem fx® Knowledge Coach and CCH Axcess™ Knowledge Coach, the efficiency of CCH® ProSystem fx® Engagement and TeamMate® Analytics, plus the comprehensive content of CCH® Accounting Research Manager® and CCH Axcess™ Financial Prep, the first dynamic cloud-based trial balance solution integrated with Xero, QBOnline, CCH Axcess™ Workstream, CCH Axcess™ Tax, as well as other cloud-based audit solutions soon to be released on the award-winning CCH Axcess™ platform.

About Wolters Kluwer Tax & Accounting

Wolters Kluwer Tax & Accounting is a leading provider of software solutions and local expertise that helps tax, accounting, and audit professionals research and navigate complex regulations, comply with legislation, manage their businesses and advise clients with speed, accuracy, and efficiency.

Wolters Kluwer Tax & Accounting is part of Wolters Kluwer (WKL), a global leader in professional information, software solutions, and services for the healthcare; tax and accounting; governance, risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

MARISA WESTCOTT

212-771-0853

[email protected]

KEYWORDS: New York Europe United States Netherlands North America

INDUSTRY KEYWORDS: Software Banking Accounting Professional Services Data Management Technology Small Business Other Professional Services Legal Finance Other Technology Consulting

MEDIA:

Logo
Logo

More Than a Third of Consumers Would Switch to Grocery Stores Offering Touchless In-Store Payments, According to New Data from ACI Worldwide

More Than a Third of Consumers Would Switch to Grocery Stores Offering Touchless In-Store Payments, According to New Data from ACI Worldwide

Digital wallets, QR codes, cards on file and POS credit options among touchless payment options preferred by consumers during pandemic

NAPLES, Fla.–(BUSINESS WIRE)–
New data from ACI Worldwide (NASDAQ: ACIW), a leading global provider of real-time digital payment software and solutions, and PYMNTS.com shows 35 percent of consumers would be willing to leave their preferred grocers for others that allow them to pay in-store in a touchless manner. The survey of more than 2,000 adult U.S. consumers, which addressed grocery shopping habits since the pandemic, also showed contactless credit cards (43%) and contactless debit cards (39%) are the two most preferred touchless payment options, followed by digital wallets (30%), cards on file (25%) and QR codes (18%).

The survey also showed that 42 percent of Millennials and 41 percent of Gen X consumers are willing to switch to grocery stores that offer touchless payment options. In addition, 17 percent of consumers who do not use contactless credit cards would like to, and 15 percent of consumers who do not use contactless debit cards would like to.

“In the wake of the pandemic, a new type of consumer is emerging, one who shops less in-store and represents a quickly growing part of the digital-first economy,” said Debbie Guerra, executive vice president, ACI Worldwide. “For grocery stores, this is a huge opportunity to cater to these consumers by providing digital and contactless payment options.”

Nearly four times more grocery shoppers (16%) have shifted to buying more groceries online than in-store compared to the start of the pandemic (4%). Overall, the survey shows that 64 percent of the U.S. population are omni-channel shoppers who make use of digital channels to buy at least some of their groceries online. The most popular delivery channels consumers have used when shopping online for groceries during the pandemic are home delivery (23%), curbside pickup (21%) and in-store pickup (12%).

“While consumers are still purchasing their groceries in-store, particularly when buying perishable items such as fresh meats, fruits and vegetables, the survey shows an increase in online grocery shopping since the pandemic began,” Guerra continued. “Consumers’ need for these necessities, coupled with the need to stay safe during the pandemic, is driving online grocery shopping whether for home delivery or curbside pickup. We expect this trend to increase as COVID-19 cases continue to climb in the U.S.”

Key Findings:

In-store vs. online grocery shopping:

  • 79 percent of all grocery shoppers still prefer to buy at least some of their groceries in-store

    • 64 percent buy at least one of their routine grocery purchases online
  • 16 percent of all grocery shoppers are buying fewer groceries in-store and more online than prior to the pandemic, compared to 4 percent who had shifted from in-store to online back in March
  • 80 percent of all consumers who buy groceries report purchasing them in-store
  • 17 percent of all consumers have switched from grocery shopping in-store to online since the start of the pandemic
  • Consumers are buying non-food items such as shampoo, first-aid items and cleaning products (21%), as well as packaged food products (14%) online
  • Consumers are purchasing items in-store when buying fruits and vegetables (83%), fresh meats (81%) and dairy products (77%)

Delivery channels

  • Consumers say they are ordering groceries online with the following delivery channels more now than they did before the pandemic:

    • Home delivery – 23%
    • Curbside pickup – 21%
    • In-store pickup – 12%
  • Grocery shoppers who shop online are acquiring their digital purchases through:

    • Home-delivery – 42%
    • Curbside pickup – 40%
    • In-store pickup – 35%

Digital and contactless payments

  • 43 percent of consumers who have never purchased groceries online would be “very” or “extremely” interested in using digital payment options, and 38 percent would be “somewhat” interested.
  • 41 percent of consumers who have already used touchless payments in-store are even more willing to make the switch
  • 37 percent of high-income and 37 percent of low-income consumers are more likely to want to shop in stores that provide touchless payments options
  • Usage of digital wallets remains relatively low compared to the growing interest in them. There is a gap between the usage and demand for digital wallets (8%) and cards on file (8.8%)

Large grocers vs. small grocers:

  • 61 percent of all consumers buy their groceries at large national chains, with Walmart being the preferred merchant for 67 percent of all consumers, followed by Target (33%) and Costco (26%)
  • 28 percent of all consumers shop at small, local grocery stores, and 14 percent buy from local convenience stores
  • 25 percent buy groceries from online grocers of all sizes

Methodology

The Omnichannel Grocery Report, a PYMNTS and ACI Worldwide collaboration, is based on a census-balanced panel of 2,066 U.S. consumers. The report assesses how consumers’ use of digital shopping channels has changed since the COVID-19 pandemic began and gauges interest in using digital payment methods to pay for their purchases.

About ACI Worldwide

ACI Worldwide powers digital payments for more than 6,000 organizations around the world. More than 1,000 of the largest financial institutions and intermediaries, as well as thousands of global merchants, rely on ACI to execute $14 trillion each day in payments and securities. In addition, myriad organizations utilize our bill presentment and payment services. Through our comprehensive suite of software solutions delivered on customers’ premises, through the public cloud or through ACI’s private cloud, we provide real-time payment capabilities and enable the industry’s most complete omni-channel payments experience.

© Copyright ACI Worldwide, Inc. 2020

ACI, ACI Worldwide, ACI Payments, Inc., ACI Pay, Speedpay and all ACI product/solution names are trademarks or registered trademarks of ACI Worldwide, Inc., or one of its subsidiaries, in the United States, other countries or both. Other parties’ trademarks referenced are the property of their respective owners.

Dan Ring

[email protected]

781-370-3600

Nidhi Alberti

[email protected]

781-370-3600

KEYWORDS: Florida United States North America

INDUSTRY KEYWORDS: Banking Software Networks Other Retail Professional Services Online Retail Internet Data Management Technology Security Retail Finance Other Technology

MEDIA:

Logo
Logo